This is a review about p53, based on 462 published articles (read how Labome selects the articles), using p53 antibody in all methods. It is aimed to help Labome visitors find the most suited p53 antibody.
p53 synonym: BCC7; LFS1; P53; TRP53; antigen NY-CO-13; mutant tumor protein 53; p53 tumor suppressor; phosphoprotein p53; transformation-related protein 53; tumor protein 53; tumor supressor p53

Knockout validation
Santa Cruz Biotechnologymouse monoclonal (DO-1)
  • WB (knockout); human; fig s1
  • WB (knockdown); human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot (knockout) on human samples (fig s1) and in western blot (knockdown) on human samples (fig 2a). Science (2015) ncbi
Santa Cruz Biotechnologymouse monoclonal (DO-1)
  • WB (knockdown); human; fig 5
  • WB (knockout); human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot (knockdown) on human samples (fig 5) and in western blot (knockout) on human samples (fig 6). Sci Rep (2015) ncbi
Abcamrabbit polyclonal
  • WB (knockout); human; fig 6
  • WB (knockdown); human; fig 5
Abcam p53 antibody (Abcam, ab17990) was used in western blot (knockout) on human samples (fig 6) and in western blot (knockdown) on human samples (fig 5). Sci Rep (2015) ncbi
Cell Signaling Technologymouse monoclonal (1C12)
  • WB (knockout); mouse; 1:2000; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot (knockout) on mouse samples at 1:2000 (fig 2a). PLoS ONE (2015) ncbi
Cell Signaling Technologyrabbit polyclonal
  • WB (knockout); mouse; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot (knockout) on mouse samples (fig 4a). Mamm Genome (2011) ncbi
Santa Cruz Biotechnology
rabbit polyclonal (FL-393)
  • WB; rat; 1:1000
  • IC; rat; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on rat samples at 1:1000 and in immunocytochemistry on rat samples at 1:500. Neuroreport (2015) ncbi
rabbit polyclonal (hSer 20)
  • IC; rat; 1:500
  • WB; rat; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-21872-R) was used in immunocytochemistry on rat samples at 1:500 and in western blot on rat samples at 1:1000. Neuroreport (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to identify negative regulators of NF-kappaB signaling, Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples. FEBS Lett (2015) ncbi
rabbit polyclonal (FL-393)
  • IP; mouse
In order to test if NR2B and CypD work together to repair synaptic injury after ischemia, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in immunoprecipitation on mouse samples. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (DO-1)
  • WB (knockout); human; fig s1
  • WB (knockdown); human; fig 2a
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot (knockout) on human samples (fig s1) and in western blot (knockdown) on human samples (fig 2a). Science (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. J Proteomics (2015) ncbi
mouse monoclonal (DO-1)
  • WB; fission yeast
In order to develop a NF-kappaB functional assay in yeast and study NF-kappaB functions, interactions, and chemical modulators, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on fission yeast samples. PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig 4g
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 4g). Mol Cancer Ther (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples and in immunocytochemistry on human samples. Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig s1.
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig s1.). Nature (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa-Cruz, sc-126) was used in western blot on human samples at 1:1000. PLoS Pathog (2015) ncbi
mouse monoclonal (DO-1)
  • IHC; human
In order to identify molecular targets that suppress tumorigenesis in triple negative breast cancers, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc., sc-126) was used in immunohistochemistry on human samples. J Clin Invest (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; 1:500; fig 5
In order to report a role for p53 in regulating the membrane phospholipids composition, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples at 1:500 (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to identify TRIM28/KAP1 as a novel ARF-binding protein and SUMO E3 ligase for NPM1/B23, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO1) was used in western blot on human samples. Mol Cell Biol (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:50
Santa Cruz Biotechnology p53 antibody (MBL Company, clone sc-47698) was used in immunohistochemistry - paraffin section on human samples at 1:50. Histopathology (2016) ncbi
goat polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in western blot on human samples. J Cell Physiol (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
In order to test if pomegranate juice protects trophoblasts from hypoxia-induced apoptosis by modulating NDRG1 expression, Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples at 1:1000. Placenta (2015) ncbi
mouse monoclonal (Pab 1801)
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-98) was used in immunocytochemistry on human samples. Cancer Cell Microenviron (2015) ncbi
mouse monoclonal (DO-1)
  • IC; human; 1:500
  • WB; human; 1:1000
In order to describe the localization of BARD1 and study its interaction with p53, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotec, sc-126) was used in immunocytochemistry on human samples at 1:500 and in western blot on human samples at 1:1000. Cell Signal (2015) ncbi
rabbit polyclonal (FL-393)
  • IP; human; 3 ugs
  • WB; human; 1:500
In order to describe the localization of BARD1 and study its interaction with p53, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotech, sc-6243) was used in immunoprecipitation on human samples at 3 ugs and in western blot on human samples at 1:500. Cell Signal (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Biomed Res Int (2015) ncbi
mouse monoclonal (DO-1)
  • IC; human; 1:250
In order to test if NBPF1 is a tumor suppressor, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in immunocytochemistry on human samples at 1:250. BMC Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotech, sc- 126) was used in western blot on human samples. Ecancermedicalscience (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:10000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:10000. J Virol (2015) ncbi
mouse monoclonal (DO-1)
  • WB (knockdown); human; fig 5
  • WB (knockout); human; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot (knockdown) on human samples (fig 5) and in western blot (knockout) on human samples (fig 6). Sci Rep (2015) ncbi
mouse monoclonal (Pab 240)
  • WB; human; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-99) was used in western blot on human samples at 1:500. PLoS ONE (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; human
In order to show that subcellular targeting bolsters the cardioprotective effects of Pim1 in primary human cardiac progenitor cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to test if base excision repair-deficient cells are a source of pre-cancerous cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Nucleic Acids Res (2015) ncbi
rabbit polyclonal (FL-393)
  • IHC-P; mouse; 1.0 ug/ml
In order to assess the use of mitotic error-induced CIN and Shugoshin1 haplo insufficient mice as models to study chromosome instability in colon cancer, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-6243) was used in immunohistochemistry - paraffin section on mouse samples at 1.0 ug/ml. Mol Carcinog (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples. J Cell Biol (2015) ncbi
mouse monoclonal (DO-1)
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples. Nucleus (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:200
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:200. Cell Signal (2015) ncbi
rabbit polyclonal (Ser 15)
  • IC; human; 1:50
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, Sc-101762) was used in immunocytochemistry on human samples at 1:50 and in western blot on human samples. Cell Signal (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; human; 1:300
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in western blot on human samples at 1:300. Mol Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:500
In order to determine if curcumin can diminish/prevent the development of cardiovascular pathologies, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:500. Toxicol Lett (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Cell Cycle (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples at 1:1000. Cell Cycle (2015) ncbi
mouse monoclonal (F-8)
  • WB; mouse; 1:500
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-374087) was used in western blot on mouse samples at 1:500. Int J Mol Med (2015) ncbi
goat polyclonal (FL-393)
  • WB; mouse; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in western blot on mouse samples (fig 2). Cell (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc, DO-1) was used in western blot on human samples. Arch Biochem Biophys (2015) ncbi
goat polyclonal (M-19)
  • FC; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-1312) was used in flow cytometry on human samples (fig 1). Stem Cells (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. J Biol Chem (2015) ncbi
rabbit polyclonal (FL-393)
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in immunocytochemistry on human samples. Genes Cells (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on human samples at 1:1000. Free Radic Biol Med (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Free Radic Biol Med (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Br J Cancer (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. FEBS Lett (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000 and in immunocytochemistry on human samples. Biochim Biophys Acta (2015) ncbi
rabbit polyclonal (hSer 20)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-18079-R) was used in western blot on human samples. Oncotarget (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000; fig s1
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, clone DO-1) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse
In order to identify the mechanistic link between Cullin neddylation and Myc ubiquitination/degradation, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples. Nat Commun (2014) ncbi
mouse monoclonal (DO-1)
  • IHC; human; 1:100
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry on human samples at 1:100. Br J Cancer (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; rat; 1:200
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC6243) was used in western blot on rat samples at 1:200. J Pineal Res (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human; fig 1
Santa Cruz Biotechnology p53 antibody (Santa, sc-47698) was used in western blot on human samples (fig 1). Nucleic Acids Res (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; fig 5
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples (fig 5). Cell Death Dis (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to investigate the role of Rap1GAP in the cell cycle regulation, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; human; 1:500; tbl 1
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on human samples at 1:500 (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig 3
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. Oncotarget (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa-Cruz Biotechnology, SC126) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • ChIP; human; fig 5b
  • WB; human; fig 1a
  • WB; mouse; fig 1f
Santa Cruz Biotechnology p53 antibody (Santa, SC-126) was used in chromatin immunoprecipitation on human samples (fig 5b) and in western blot on human samples (fig 1a) and on mouse samples (fig 1f). Oncotarget (2014) ncbi
  • WB; human
  • IP; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-45917) was used in western blot on human samples and in immunoprecipitation on human samples. Oncotarget (2014) ncbi
rabbit polyclonal (FL-393)
  • IP; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in immunoprecipitation on human samples. Oncotarget (2014) ncbi
mouse monoclonal (C-11)
  • WB; human
In order to determine the effect of zerumbone on p53 signaling and assess if zerumbone has anti-cancer effects on non-small cell lung cancer, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-55476) was used in western blot on human samples. Biochimie (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc6243) was used in western blot on human samples at 1:1000. Neoplasia (2014) ncbi
mouse monoclonal (DO-1)
  • IC; human; fig 4
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunocytochemistry on human samples (fig 4). Immunol Lett (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to investigate the sensitization of cancer cells by c-Abl inhibition, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • IHC; human; 1:5000
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in immunohistochemistry on human samples at 1:5000. PLoS ONE (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; 1:1000; fig 6
In order to study the role of Pax6 in the maintenance and differentiation of adult neural stem cells and in adult neurogenesis, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples at 1:1000 (fig 6). Stem Cells Dev (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 0.2 ug/ml
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 0.2 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to study the effect of Hinokitiol on DNA damage and autophagy in gefitinib-resistant lung adenocarcinoma cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (Pab 240)
  • WB; human
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, Pab240) was used in western blot on human samples and on mouse samples. Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:2000; fig 5h
In order to show that the zinc finger E-box binding homeobox 1 regulates radiosensitivity and the DNA damage response in breast cancer cells, Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples at 1:2000 (fig 5h). Nat Cell Biol (2014) ncbi
goat polyclonal (C-19)
  • WB; rat; 1:100
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-1311) was used in western blot on rat samples at 1:100. Exp Gerontol (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples at 1:1000. J Biol Chem (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to develop high throughput methods to assess proof-of-concept in vitro-only risk assessments, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Toxicol Sci (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. Biochem Biophys Res Commun (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples. elife (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. Biochem Biophys Res Commun (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on human samples. Oncogene (2015) ncbi
mouse monoclonal (Pab 1801)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-98) was used in western blot on human samples. Cell Death Dis (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. Cell Death Dis (2014) ncbi
mouse monoclonal (DO-1)
  • IP; human
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in immunoprecipitation on human samples and in western blot on human samples. Oncogene (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples. Arch Pharm Res (2015) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in western blot on human samples. Mol Cell Biol (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (SantaCruz Biotechnology, sc-6243) was used in western blot on mouse samples. J Innate Immun (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; rat; 1:100
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on rat samples at 1:100. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples and on mouse samples. PLoS ONE (2014) ncbi
rabbit polyclonal (FL-393)
  • ChIP; human
Santa Cruz Biotechnology p53 antibody (Santa, FL393) was used in chromatin immunoprecipitation on human samples. Cell Death Dis (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Front Endocrinol (Lausanne) (2014) ncbi
mouse monoclonal (Bp53-12)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-263) was used in western blot on human samples. elife (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Cell Death Dis (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; human
In order to evaluate large subunit ribosomal proteins as therapeutic targets for melanoma, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on human samples. Pigment Cell Melanoma Res (2014) ncbi
goat polyclonal (mSer 20)
  • WB; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-18078) was used in western blot on mouse samples. PLoS ONE (2014) ncbi
goat polyclonal (FL-393)
  • ChIP; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243x) was used in chromatin immunoprecipitation on mouse samples. PLoS ONE (2014) ncbi
mouse monoclonal (Pab 240)
  • WB; mouse
In order to demonstrate a novel role for Poldip2 in regulating the cell cycle, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on mouse samples. PLoS ONE (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples. Aging Cell (2014) ncbi
goat polyclonal (FL-393)
  • IHC-P; mouse
  • IC; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243G) was used in immunohistochemistry - paraffin section on mouse samples and in immunocytochemistry on mouse samples. Mol Cancer Ther (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to study the involvement of RASSF1A inactivation in carcinogenesis, Santa Cruz Biotechnology p53 antibody (Santa Cruz., sc-126) was used in western blot on human samples. Mol Cell Biol (2014) ncbi
mouse monoclonal (Bp53-12)
  • WB; human
  • IP; human
In order to study the role in prostate cancer poliferation of a complex containing COP9 subunits 4 and 5 along with sGC-alpha1 and p53, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-263) was used in western blot on human samples and in immunoprecipitation on human samples. Mol Endocrinol (2014) ncbi
mouse monoclonal (DO-1)
  • ChIP; human
In order to elucidate TP53-mediated oncogenic transformation of epithelial cells, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in chromatin immunoprecipitation on human samples. Sci Rep (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig 2
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotech, DO-1) was used in western blot on human samples (fig 2). Nature (2014) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 antibody was used to perform western blotting in order to study JMJD6 promotes colon carcinogenesis through negative regulation of p53.PLoS Biol (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IP; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples and in immunoprecipitation on human samples. Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IC; human; 1:300
In order to study the effect of a UBE2N inhibitor on neuroblastoma and its mechanism, Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples and in immunocytochemistry on human samples at 1:300. Cell Death Dis (2014) ncbi
goat polyclonal (FL-393)
  • IP; human
In order to study the role of a p53-miRNA-34 positive-feedback loop in tumor suppression in lung cancer, Santa Cruz Biotechnology p53 antibody (Santa, FL-393-G) was used in immunoprecipitation on human samples. Genes Dev (2014) ncbi
mouse monoclonal (Pab 240)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-99) was used in western blot on human samples. ScientificWorldJournal (2014) ncbi
mouse monoclonal (D-11)
  • WB; human; 1:500
In order to determine the cellular function of Lyar, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-17846) was used in western blot on human samples at 1:500. Genes Cells (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. Cell Death Differ (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples and in immunocytochemistry on human samples. Mol Oncol (2014) ncbi
mouse monoclonal (DO-1)
  • EMSA; mouse
  • EMSA; rat
In order to study the upregulation of pancreatic beta cell ARAP1 by a functional regulatory DNA variant at a type 2 diabetes locus, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126X) was used in EMSA on mouse samples and on rat samples. Am J Hum Genet (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:2000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:2000. Nucleic Acids Res (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on mouse samples. J Biol Chem (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-6243) was used in western blot on mouse samples at 1:1000. Cell Mol Neurobiol (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. FEBS J (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa, sc-126) was used in western blot on human samples. Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IC; human
  • IP; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples, in immunocytochemistry on human samples, and in immunoprecipitation on human samples. Cell Cycle (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; 1:2000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on mouse samples at 1:2000. Cancer Res (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples. Br J Cancer (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. Cell Cycle (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, SC-126) was used in western blot on human samples at 1:1000. Exp Cell Res (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples. Nucleic Acids Res (2013) ncbi
rabbit polyclonal (FL-393)
  • IHC-F; mouse
  • WB; human
  • WB; mouse
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in immunohistochemistry - frozen section on mouse samples and in western blot on human samples and on mouse samples. J Am Heart Assoc (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Mol Cancer (2013) ncbi
mouse monoclonal (DO-1)
  • WB; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on mouse samples. J Neurosci (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. J Biol Chem (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig 3
In order to investigate the function of ING4 in normal, non-transformed primary fibroblasts, Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO-1) was used in western blot on human samples (fig 3). Oncogene (2014) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, FL-393) was used in western blot on human samples. Blood (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. Biochem J (2013) ncbi
mouse monoclonal (DO-1)
  • IC; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in immunocytochemistry on human samples. EMBO J (2013) ncbi
rabbit polyclonal (FL-393)
  • WB; mouse; 1:200
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-6243) was used in western blot on mouse samples at 1:200. J Biol Chem (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-126) was used in western blot on human samples. Mol Oncol (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc126) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples. Nucleic Acids Res (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. Nucleic Acids Res (2013) ncbi
rabbit polyclonal (Ser 15)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-101762) was used in western blot on human samples. Mech Ageing Dev (2012) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on human samples. Mech Ageing Dev (2012) ncbi
rabbit polyclonal (FL-393)
  • WB; rat
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on rat samples. Mol Biol Cell (2012) ncbi
mouse monoclonal (Bp53-12)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-263) was used in western blot on human samples. Cell Cycle (2012) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology Inc, FL-393) was used in western blot on human samples. PLoS ONE (2012) ncbi
rabbit polyclonal (FL-393)
  • WB; human
In order to exmaine the expression of unfolded protein response genes in endoplasmic reticulum stress, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-6243) was used in western blot on human samples. Cell Stress Chaperones (2013) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 was used to perform western blot in order to show that cell fate was regulated by p53 dynamics.Science (2012) ncbi
rabbit polyclonal (FL-393)
  • IHC-P; rat; 1:400
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc6243) was used in immunohistochemistry - paraffin section on rat samples at 1:400. Histochem Cell Biol (2012) ncbi
not indicated
  • WB; human
  • ChIP; human
Santa Cruz Biotechnology anti-p53 antibody was used to perform western blot and ChIP in order to show that p53-dependent cell proliferation and survival could be regulated by atg7.Science (2012) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-p53 was used to perform western blot in order to study the role of p53 in the differentiation of human embryonic stem cells.PLoS Biol (2012) ncbi
not indicated
  • WB; human
  • IC; human
Santa Cruz anti-p53 was used to perform western blot and immunocytochemistry in order to show that chromosomal structural aberrations could be caused by chromosome segregation errors.Science (2011) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, SC-126) was used in western blot on human samples. J Ethnopharmacol (2011) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc-126) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2011) ncbi
rabbit polyclonal (Ser 46)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-101764) was used in western blot on human samples. Cell Death Differ (2011) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 antibody was used in western blot to study the effect of the candidate tumor suppressor gene ECRG4 on cancer cells migration and invasion in esophageal carcinoma.J Exp Clin Cancer Res (2010) ncbi
mouse monoclonal (Pab 246)
  • ChIP; human
Santa Cruz Biotechnology anti-p53 antibody was used to carry out ChIP assays in order to investigate the mechanism for AMP-activated protein kinase regulating cellular responses to metabolic stress.Science (2010) ncbi
rabbit polyclonal (FL-393)
  • IC; Rhesus monkey; fig 6
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in immunocytochemistry on Rhesus monkey samples (fig 6). J Virol (2010) ncbi
not indicated
  • WB; human
Santa Cruz mouse anti-p53 was used to perform western blot in order to study the relation between Drosophila p53 and the human p53 network.Proc Natl Acad Sci U S A (2010) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology Inc anti-p53 antibody was used for western blot in order to investigate the role of TGFB1 in the regulation of Mdm2 expression and late-stage breast cancer metastasis.J Clin Invest (2010) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, DO1) was used in western blot on human samples. Mol Cell (2009) ncbi
rabbit polyclonal (FL-393)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, sc6243) was used in western blot on human samples. J Mol Endocrinol (2010) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-p53 antibody was used for western blot in order to investigate the role of DJ-1 mutations in the regulation of Parkinson disease pathology.Cell Death Differ (2010) ncbi
not indicated
  • WB; human
Santa Cruz biotechnology p53 antibody was used to perform western blot in order to investigate the relations between SIK1 and anoikis, metastasis.Sci Signal (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-p53 antibody was used for western blot in order to investigate the role of hnRNPK in pancreatic cancer.Int J Cancer (2010) ncbi
not indicated
  • WB; human
  • IHC; human
Santa Cruz anti-p53 antibody was used to perform western blot and immunohistochemistry in order to study the function of HP1 proteins in the alternative lengthening of telomeres-associated PML bodies by p53/p21.J Cell Biol (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-p53 antibody was used for western blot in order to investigate the role of ARIA in the regulation of endothelial apoptosis and angiogenesis.PLoS ONE (2009) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 antibody was used to perform western blot in order to show that the absence of p53 can result in tumourgenesis in those mesenchymal stem cells lacking p21.Neoplasia (2009) ncbi
not indicated
  • WB; human
Santa Cruz mouse anti-p53 monoclonal antibody was used in western blot to investigate the role of hypoxia in the regulation of human lung fibroblast proliferation.Respir Res (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology mouse monoclonal anti-p53 antibody was used for western blot in order to investigate the role of Aurora B in the regulation of postmitotic endoreduplication checkpoint.Mol Biol Cell (2009) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology p53 antibody was used for western blot in order to show that the cancer cells with inactivated p53 were highly sensitive to PLK1 inhibitors.Proc Natl Acad Sci U S A (2009) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 was used to perform western blot in order to prove that the catalytic activity of IKK modified with O-GlcNAc in p53-deficient cells is enhanced.Proc Natl Acad Sci U S A (2009) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 Ab was used to detect p53 in western blot in order to find out the novel mechanism by which eIF4E levels are regulated at the level of mRNA stabilityMol Cell Biol (2009) ncbi
not indicated
  • WB; human
Santa Cruz goat-polyclonal anti-p53 was used to perform western blot in order to study the function of beta-catenin in mediating the effects of ionizing radiation in fibroblasts.Am J Pathol (2009) ncbi
not indicated
  • WB; human
Santa Cruz anti-p53 antibody (DO-1) was used in western blot to study the role for Hsp72 in suppression of the oncogene-induced senescence.Mol Cell Biol (2009) ncbi
not indicated
  • WB; human
  • IP; human
Santa-Cruz Biotechnology anti-p53 antibodies (DO-1 or PAb1801) and anti-p53 antibody (PAb1801) conjugated beads were used in western blot and immunoprecipitation to study the effect of simian virus 40 large T antigen on genome integrity and DNA damage response.J Virol (2009) ncbi
not indicated
  • WB; human
Santa Cruz monoclonal anti-p53 (DO-1) was used to perform western blot in order to show that mTOR is identified as a regulator of p73 by a gene signature-based approach.Mol Cell Biol (2008) ncbi
not indicated
  • IP; human
Santa Cruz Biotechnology anti-p53 antibody was used in immunoprecipitation to study the mechanism and effect of p53 activation by a potent and specific MDM2 antagonist (MI-43) in colon cancer.Mol Cancer Ther (2008) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biot, DO-1) was used in western blot on human samples. Cell Res (2008) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology mouse monoclonal p53 antibody was used in western blot in order to examine the effects of combining a proteasome inhibitor with an HDAC inhibitor in GBM cell linesNeuro Oncol (2008) ncbi
mouse monoclonal (DO-1)
  • WB; human
In order to investigate the potential role of the proteasome in checkpoint activation and ATM/ATR signaling in response to UV light-induced DNA damage, Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, DO-1) was used in western blot on human samples. J Biol Chem (2008) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-p53 antibody was used to perform western blot in order to study the contribution of hSRBC epigenetic inactivation to the malignant progression in gastric cancer through attenuated p53 response to stresses.Int J Cancer (2008) ncbi
not indicated
  • WB; human
Santa Cruz monoclonal anti-p53 was used to perform western blot in order to show that global sumoylation and Pias3 stabilization could be regulated by nitric oxide.PLoS ONE (2007) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology p53 antibody was used in western blot to report an increase in S100A6 protein level in colon and lung cancer cells postexposure to ionizing radiation.Mol Cell Proteomics (2007) ncbi
not indicated
  • IHC; human
Santa Cruz Biotechnology monoclonal anti-p53 antibody (DO-1) was used in immunohistochemistry to study the relationship between angiogenesis markers with lymph node metastasis in early colorectal cancer in paraffin sections from human tumor.Arch Surg (2007) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology p53 antibody was used in western blot to investigate the role of these complexes in the biology of mesenchymal stem cells (MSCs).J Cell Sci (2007) ncbi
not indicated
  • IC; human
Santa Cruz Biotechnology anti-P53 antibody was used in immunocytochemistry (1:400) to demonstrate that heparanase was expressed in lymphocytes of breast cancer PBMC.Neoplasia (2007) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology p53 antibody was used in western blot to study the role of MEG3 in tumor suppression.J Biol Chem (2007) ncbi
not indicated
  • IC; human
SantaCruz Biotechnology anti-pp53 (Ser-20 p53) antibody was used in human cells and in immunocytochemistry to study the role for p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells.Mol Cancer (2007) ncbi
mouse monoclonal (DO-1)
  • WB; human
Santa Cruz anti-p53 antibody was used to perform western blot in order to study the dependency on oxidative phosphorylation during transformation of human mesenchymal stem cells.Proc Natl Acad Sci U S A (2007) ncbi
not indicated
  • WB; human
Santa Cruz anti-human-p53 antibody was used in western blot to identify p18 (Hamlet) as a new cell-fate regulator.EMBO J (2007) ncbi
mouse monoclonal (Pab 240)
  • WB; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz Biotechnology, sc-99) was used in western blot on human samples. Oncogene (2007) ncbi
mouse monoclonal (Pab 240)
  • WB; mouse; 1:500; fig 1a
Santa Cruz Biotechnology p53 antibody (Santa, sc-99) was used in western blot on mouse samples at 1:500 (fig 1a). Nucleic Acids Res (2006) ncbi
not indicated
  • WB; human
Santa Cruz p53 antibody was used in western blot to identify Traf4 interacting proteins.Cancer Biol Ther (2006) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology TP53 antibody was used in western blot to study the association between maspin expression with distinct clinicopathological parameters and TP53 expression in a representative series of primary non-small cell lung cancer (NSCLC).J Clin Pathol (2007) ncbi
not indicated
  • IP; human
Santa Cruz Biotechnology anti-p53 antibody was used in human HCT116 cells and in immunoprecipitation to study the role for FAT10 in the regulation of chromosomal stability.J Biol Chem (2006) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology mouse monoclonal anti-p53 antibodies (sc-99 or sc-126) was used in Chinese hamster CHO-OX1 cells with human OX1 receptors and in western blot to study the role of G-protein-coupled receptor signaling in cell death via p38 mitogen-/stress-activated protein kinase independent of p53 and caspase activation.J Biol Chem (2006) ncbi
not indicated
  • IC; human
  • IP; human
  • WB; human
SCBT monoclonal anti-p53 DO-1 antibody was used in western blot, immunoprecipitation, and immunocytochemistry to investigate the regulation of p53 by GSK through MDM2.Mol Cell Biol (2005) ncbi
not indicated
  • WB; human
SCBT anti-p53 antibody (DO-1) was used in western blot to investigate the regulation of Cdc6 protein stability by p53.Mol Cell Biol (2005) ncbi
not indicated
  • WB; human
SCBT anti-p53 DO-1 antibody was used in western blot to investigate the decrease of COX-2 Levels through p53 and NFkB by T-oligo.J Biol Chem (2005) ncbi
not indicated
  • WB; human
  • ChIP; human
SCBT anti-p53 antibody was used in western blot and ChIP assays to investigate the regulation of death receptor 5 expression by NFKB1Mol Cell Biol (2005) ncbi
not indicated
  • WB; human
SCBT anti-p53 (FL393) and anti-p53 (DO-1) antibodies were used in western blot to study the induction of neuroblastoma cell apoptosis by TrkAJ Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IP; human
  • IHC; human
  • IC; human
SCBT monoclonal mouse anti-human p53-DO-1 (p53-DO-1) antibody was used in immunohistochemistry, immunocytochemistry, western blot, and immunoprecipitation, and monoclonal mouse anti-human p53-1801 (p53-1801) antibody was used in immunohistochemistry to study the interaction between calcium-binding protein S100A2 and p53J Biol Chem (2005) ncbi
not indicated
  • WB; human
  • ELISA; human
Santa Cruz Biotechnology monoclonal anti-p53 antibody Bp53-12 was used in western blot and ELISA to study the p53-induced Gene-6 (proline oxidase) which mediates apoptosis through a calcineurin-dependent pathway.J Biol Chem (2005) ncbi
not indicated
  • WB; human
SCBT rabbit polyclonal anti human p53 antibody was used in western blot to study the apoptosis in p53-defective tumorsJ Natl Cancer Inst (2005) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology Inc p53 antibody was used in western blot to study the effect of human p53 serine 46 phosphorylation on promoter selection and apoptosisJ Biol Chem (2005) ncbi
not indicated
  • WB; human
Santa Cruz p53 antibody was used in western blot to study p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2J Cell Sci (2005) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology p53 antibody was used in western blot to demonstrate that 15-PGDH induce apoptosis and function like a tumor suppressor.Carcinogenesis (2005) ncbi
goat polyclonal (FL-393)
  • IP; human
Santa Cruz Biotechnology p53 antibody (Santa Cruz, FL-393) was used in immunoprecipitation on human samples. Mol Cell Biol (2003) ncbi
Invitrogen
mouse monoclonal (DO-1)
  • IHC; human; 1:200; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, Invitrogen p53 antibody (Thermo Scientific, p53 Ab-6 (Clone DO-1)) was used in immunohistochemistry on human samples at 1:200 (fig 3). Gastroenterology (2015) ncbi
mouse monoclonal (PAB1801)
  • WB; human
In order to show that the INO80 complex negatively regulates the p21Waf1/Cip1 expression in a p53-mediated mechanism, Invitrogen p53 antibody (ZYMED, 13-4000) was used in western blot on human samples. PLoS ONE (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:200
Invitrogen p53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:200. Pathol Res Pract (2015) ncbi
rabbit monoclonal (SP5)
  • IHC; human; 1:200
Invitrogen p53 antibody (Thermo, SP5) was used in immunohistochemistry on human samples at 1:200. Urol Oncol (2015) ncbi
mouse monoclonal (DO-1)
  • WB; human
  • IP; human
In order to study the homo- and heterodimerization of an E3 ligase MDM2, Invitrogen p53 antibody (Labvision, DO-1) was used in western blot on human samples and in immunoprecipitation on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:400
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on human samples at 1:400. Gynecol Oncol (2015) ncbi
mouse monoclonal (X77)
  • WB; common platanna; 1:800
In order to determine the role of NOL11 in vertebrate ribosome biogenesis and craniofacial development, Invitrogen p53 antibody (Thermo Scientific, MA1-12549) was used in western blot on common platanna samples at 1:800. PLoS Genet (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human; fig 1
In order to report that p53 and DeltaNp63alpha are transcriptional partners for SMAD proteins, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in western blot on human samples (fig 1). Mol Cancer Res (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:400
In order to describe a patient diagnosed with a noninvasive intestinal-type mucinous ovarian borderline tumor presenting with pleural metastases, Invitrogen p53 antibody (Thermo Fisher Scientific, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:400. Int J Gynecol Pathol (2015) ncbi
mouse monoclonal (Pab 240)
  • WB; human; 1:5000
In order to study the inhibitory effect of 3-bromopyruvate in an animal model of gastric cancer, Invitrogen p53 antibody (Invitrogen, AHO0112) was used in western blot on human samples at 1:5000. Oncol Lett (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen p53 antibody (LabVisio, DO-7) was used in immunohistochemistry - paraffin section on human samples. APMIS (2015) ncbi
mouse monoclonal (DO-7 + BP53-12)
  • IHC; human; 1:100
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen p53 antibody (Lab Vision, DO-7+BP53-12) was used in immunohistochemistry on human samples at 1:100. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (DO-1)
  • IHC-P; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen p53 antibody (Thermo Scientific, MS187) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:50
In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen p53 antibody (LabVision, DO-7) was used in immunohistochemistry on human samples at 1:50. Arch Dermatol Res (2015) ncbi
mouse monoclonal (PAB1801)
  • WB; human; fig 1
In order to study the effect of ceramide treatment on p53, Invitrogen p53 antibody (Invitrogen, 13-4000) was used in western blot on human samples (fig 1). Biochim Biophys Acta (2014) ncbi
rabbit monoclonal (14H61L24)
  • IHC-P; human; 1:400
In order to investigate Bcl2 expression in colorectal adenocarcinoma, Invitrogen p53 antibody (Invitrogen, 700439) was used in immunohistochemistry - paraffin section on human samples at 1:400. J Am Coll Surg (2014) ncbi
rabbit monoclonal (14H61L24)
  • WB; human
In order to develop high throughput methods to assess proof-of-concept in vitro-only risk assessments, Invitrogen p53 antibody (Invitrogen, 700439) was used in western blot on human samples. Toxicol Sci (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:250
Invitrogen p53 antibody (Neomarkers, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:250. Am J Clin Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen p53 antibody (Thermo Scientific, DO-7) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (BP53-12)
  • IHC; rat; 1:100; fig 1, 2, 3
In order to study the effect of artificial food colors and additives on laryngeal histomorphology and immunohistochemical expression in maternally exposed rats, Invitrogen p53 antibody (Thermo Scientific, BP53-12) was used in immunohistochemistry on rat samples at 1:100 (fig 1, 2, 3). J Environ Pathol Toxicol Oncol (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
In order to describe a new polymeric-phospholipidic hybrid delivery system which enhanced the accumulation and activity of Dox in all tested cancer cell lines, Invitrogen p53 antibody (NeoMarkers, Do-1) was used in western blot on human samples at 1:1000. J Biomed Nanotechnol (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human
Invitrogen p53 antibody (Invitrogen, CA#AHO0152) was used in western blot on human samples. Arch Biochem Biophys (2014) ncbi
mouse monoclonal (PAb 240)
  • IHC; mouse
Invitrogen p53 antibody (Invitrogen, PAb 240) was used in immunohistochemistry on mouse samples. Tumour Biol (2014) ncbi
mouse monoclonal (PAb 1801)
  • IC; human; 1:100
  • WB; human; 1:500
Invitrogen p53 antibody (Biosource, PAb 1801) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (Pab 240)
  • IHC-P; chicken
In order to study the expression of protein p53 in Gallus gallus domesticus, Invitrogen p53 antibody (Invitrogen, AHO0112) was used in immunohistochemistry - paraffin section on chicken samples. Cell Tissue Res (2014) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human; 1:200; fig 1
In order to assess the association between methylation of the FHIT gene and its expression in breast cancer, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Oncol Rep (2013) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human; 1:500; tbl 1
In order to measure the expression of VEGF, HIF-1alpha, and CD34 in breast tumors and correlate the findings with clinical and pathological variables, Invitrogen p53 antibody (Zymed, clone BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 1). Acta Histochem (2014) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human; 1:100; fig 2
In order to study triple negative breast cancer in Chinese women, Invitrogen p53 antibody (Zymed, clone BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Int J Clin Exp Pathol (2013) ncbi
mouse monoclonal (DO-1)
  • IHC-P; human; 1:100
In order to study the predictive and prognostic value of a range of biomarkers in pre-treatment biopsies from patients with advanced cancer of the larynx, Invitrogen p53 antibody (Lab Vision, DO-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Laryngoscope (2014) ncbi
mouse monoclonal (Pab 240)
  • WB; human; fig 3
In order to describe selected reaction monitoring mass spectrometry, Invitrogen p53 antibody (Invitrogen, clone AHO0112) was used in western blot on human samples (fig 3). J Proteome Res (2013) ncbi
mouse monoclonal (DO-7)
  • IHC; human
In order to report and characterize two cases of accessory breast cancer occurring concurrently with primary invasive breast cancer, Invitrogen p53 antibody (Zymed, DO-7) was used in immunohistochemistry on human samples. Cancer Biol Med (2012) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human
In order to determine the relationship of AEG-1 and p53 with the prognostic parameters of renal cell carcinoma, Invitrogen p53 antibody (Zymed, clone BP53-12) was used in immunohistochemistry - paraffin section on human samples. Pol J Pathol (2013) ncbi
mouse monoclonal (BP53-12)
  • IHC; human; 1:200
  • WB; human; 1:250; fig 2
In order to determine the localization and expression of RARalpha, RARbeta, and RARgamma in bull and dog sperm, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry on human samples at 1:200 and in western blot on human samples at 1:250 (fig 2). Theriogenology (2013) ncbi
mouse monoclonal (BP53.12)
  • IC; human; fig 4
In order to study the role of p53 and p21 in apoptosis using congenital cholesteatoma samples, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunocytochemistry on human samples (fig 4). Otol Neurotol (2013) ncbi
mouse monoclonal (PAB1801)
  • WB; human; 1:2000; fig 3
In order to study the cellular changes induced by resveratrol using Hodgkin lymphoma-derived L-428 cells, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples at 1:2000 (fig 3). Int J Cancer (2013) ncbi
mouse monoclonal (DO-7 + BP53-12)
  • WB; mouse; 1:500
In order to study the role of TGF-beta inhibitors in abolishing the resistance of glioblastoma to ionozing radiation therapy, Invitrogen p53 antibody (Neomarkers, MS-738-P) was used in western blot on mouse samples at 1:500. Cancer Res (2012) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; mouse; fig 6
In order to assess the role of age on expression of p53-target genes, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Mech Ageing Dev (2012) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human; 1:500; tbl 2
In order to study the expression, regulation and function of IL-8 in breast cancer, Invitrogen p53 antibody (Zymed, 18-0129) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 2). Acta Histochem (2012) ncbi
mouse monoclonal (PAb 240)
  • IHC; mouse; 1:250; fig s1
In order to investigate the origin of UV-induced squamous cell carcinomas, Invitrogen p53 antibody (Thermo Fisher Scientific, Pab240) was used in immunohistochemistry on mouse samples at 1:250 (fig s1). Carcinogenesis (2012) ncbi
mouse monoclonal (DO-1)
  • WB; human; fig 1
In order to develop a method to quantify p53 degradation activity of E6 in vivo and assess HPV variants, Invitrogen p53 antibody (Invitrogen, AHO0152) was used in western blot on human samples (fig 1). J Virol (2012) ncbi
mouse monoclonal (BP53.12)
  • IHC; human
In order to examine human papillomavirus type 16 status and the expression levels of a defined set of biomarkers for head and neck squamous cell carcinoma to identify predictors of treatment, Invitrogen p53 antibody (Zymed, clone BP53-12) was used in immunohistochemistry on human samples. Cancer (2012) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human; 1:500; tbl 5
In order to correlate expression of the glutathione S-transferase pi isoenzyme for the prognosis and treatment of invasive ductal carcinoma, Invitrogen p53 antibody (Zymed, 18-0129) was used in immunohistochemistry - paraffin section on human samples at 1:500 (tbl 5). Acta Histochem (2012) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human; fig 3
In order to report a case of pituicytoma with unusual histological features mimicking ependymoma, Invitrogen p53 antibody (Invitrogen, BP53.12) was used in immunohistochemistry - paraffin section on human samples (fig 3). Pathol Int (2011) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; fig 1
In order to determine the roles of p53 and hMSH2 proteins in oral squamous cell carcinoma and oral dysplastic lesions, Invitrogen p53 antibody (Zymed, Do7) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oral Oncol (2012) ncbi
mouse monoclonal (PAB1801)
  • WB; human; fig 1
In order to study clusterin in Hodgkin's lymphoma-derived cell lines, Invitrogen p53 antibody (Zymed, PAB1801) was used in western blot on human samples (fig 1). Int J Oncol (2011) ncbi
not indicated
  • IHC; human
Zymed monoclonal mouse anti-human p53 antibody (clone BP53.12) was used in immunohistochemistry to demonstrate whether overexpression of EMP3 in primary breast carcinoma is not associated with DNA methylationJ Korean Med Sci (2009) ncbi
not indicated
  • WB; human
Neo Markers Inc. anti-p53 was used to perform western blot in order to prove that the catalytic activity of IKK modified with O-GlcNAc in p53-deficient cells is enhanced.Proc Natl Acad Sci U S A (2009) ncbi
not indicated
  • WB; human
Invitrogen p53 antibody was used in western blot in order to investigate whether MMC induces cellular apoptosis in corneal endothelial cellsMol Vis (2008) ncbi
not indicated
  • IHC; human
Lab Vision rabbit monoclonal anti-p53 antibody (1:25) was used in immunohistochemistry in order to investigate the expression of p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 in human corneal endothelial cell (HCEC) senescence ex vivo at various donor agesMol Vis (2008) ncbi
not indicated
  • WB; human
NeoMarkers anti-p53 antibody was used in human T-cell leukemia cell lines and in western blot to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.Retrovirology (2006) ncbi
not indicated
  • IHC; human
Neomarkers Biotechnical Company mouse monoclonal anti-human p53 antibody was used in immunohistochemistry to detect p53 in colon cancer tissues.World J Gastroenterol (2005) ncbi
mouse monoclonal (BP53-12)
  • IC; Rhesus monkey; fig 9
  • IC; human; fig 9
In order to examine the role of PSF-TFE3 fusion protein in mediating cell transformation, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on Rhesus monkey samples (fig 9) and on human samples (fig 9). Oncogene (2003) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human; 1:50; fig 5
In order to report a case of ovarian borderline endometrioid tumor showing the morules associated with optically clear nuclei, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5). APMIS (2002) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human
In order to compare ways to detect human hepatocellular carcinoma, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples. J Korean Med Sci (2002) ncbi
mouse monoclonal (BP53.12)
  • IC; human
In order to investigate p16-related senescence using keratinocytes, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on human samples. Mol Cell Biol (2002) ncbi
mouse monoclonal (PAb 1801)
  • IHC-P; human
In order to determine the immunoexpression of deleted in colon cancer, p53, E-cadherin, and beta-catenin in the duodenal mucosa of children with coeliac disease, Invitrogen p53 antibody (Zymed, 1801) was used in immunohistochemistry - paraffin section on human samples. J Clin Pathol (2001) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human
In order to characterize surgically resected non-small cell lung cancers, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples. J Korean Med Sci (2001) ncbi
mouse monoclonal (PAB1801)
  • WB; human
In order to investigate the relationship between androgen receptor and p53, Invitrogen p53 antibody (Zymed, 13-4000) was used in western blot on human samples. J Biol Chem (2001) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:50; fig 1
In order to test if Ki-67, proliferating cell nuclear antigen, silver-staining nucleolar organizer regions and p53 could differentiate spontaneous abortions from subtypes of gestational trophoblastic diseases, Invitrogen p53 antibody (Zymed Laboratories, clone DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Am J Obstet Gynecol (2001) ncbi
mouse monoclonal (PAB240)
  • WB; mouse; 1:1000; fig 1
In order to test if p53 and MMR mediate X-ray cytotoxicity via the same pathway, Invitrogen p53 antibody (Zymed Laboratories, 13-4100) was used in western blot on mouse samples at 1:1000 (fig 1). Cancer Res (2000) ncbi
mouse monoclonal (BP53.12)
  • IC; human
In order to elucidate the relationships among telomerase activity, cell cycle control, senescence, and differentiation using keratinocytes and mesothelial cells, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunocytochemistry on human samples. Mol Cell Biol (2000) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human
In order to study the expression of tumor markers associated with chemotherapy resistance, Invitrogen p53 antibody (Zymed, BP53.12) was used in immunohistochemistry - paraffin section on human samples. Clin Cancer Res (1999) ncbi
mouse monoclonal (BP53-12)
  • IC; human; tbl 4
In order to examine if specific tumor or biologic factors were predictive of chemotherapy response, organ preservation, or survival in patients with advanced laryngeal cancer, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunocytochemistry on human samples (tbl 4). Otolaryngol Head Neck Surg (1999) ncbi
mouse monoclonal (BP53.12)
  • IHC-P; human; 1:100; fig 1, 2
In order to study p53 and Ki-67 in Kaposi's sarcoma samples, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1, 2). Am J Dermatopathol (1999) ncbi
mouse monoclonal (BP53.12)
  • IHC; human; 1:10; fig 5
In order to characterize vein bypass atherectomy specimens, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry on human samples at 1:10 (fig 5). Atherosclerosis (1998) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human
In order to determine the expression of p53, Rb, and bcl-2 during the cell cycle in stimulated peripheral blood lymphocytes and microwave heated reactive lymphoid tissue sections, Invitrogen p53 antibody (Zymed, BP53-12) was used in immunohistochemistry - paraffin section on human samples. J Clin Pathol (1995) ncbi
mouse monoclonal (BP53-12)
  • IHC-P; human
In order to discuss why p53 mutations may not be detected in cancer, Invitrogen p53 antibody (Zymed, Bp53.12) was used in immunohistochemistry - paraffin section on human samples. Cancer (1995) ncbi
EMD Millipore
mouse monoclonal (BP53-12)
  • WB; human
EMD Millipore p53 antibody (Upstate Biotechnology, BP53-12) was used in western blot on human samples. J Biomed Sci (2015) ncbi
mouse monoclonal (BP53-12)
  • IC; human; 1:1000
In order to investigate the interactions between focal adhesion kinase and p53 in neuroblastoma, EMD Millipore p53 antibody (Millipore, BP53-12) was used in immunocytochemistry on human samples at 1:1000. J Surg Res (2015) ncbi
mouse monoclonal
  • IHC; human; 1:50
EMD Millipore p53 antibody (EMD, OP09-100UG) was used in immunohistochemistry on human samples at 1:50. Mol Cancer Res (2015) ncbi
rabbit monoclonal (EPR358(2))
  • WB; human; 1:1000; fig s1
EMD Millipore p53 antibody (Millipore, 04-1146) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2014) ncbi
mouse monoclonal (DO-1)
  • IHC-P; human; 1 ug/ml
EMD Millipore p53 antibody (EMD Millipore Calbiochem, DO-1) was used in immunohistochemistry - paraffin section on human samples at 1 ug/ml. BMC Clin Pathol (2014) ncbi
rabbit monoclonal (Y5)
  • IP; mouse
In order to study the interaction between DAPK1 and p53 as the point of convergence of the apoptotic and necrotic pathways involved in ischemic neuronal cell death, EMD Millipore p53 antibody (Millipore, 04-1083) was used in immunoprecipitation on mouse samples. J Neurosci (2014) ncbi
mouse monoclonal (DO-1)
  • IHC-P; human; 1:50
EMD Millipore p53 antibody (Oncogene Research Products, DO1) was used in immunohistochemistry - paraffin section on human samples at 1:50. Hum Pathol (2014) ncbi
rabbit monoclonal (EPR358(2))
  • WB; human; 1:2000
EMD Millipore p53 antibody (Millipore, 04-1146) was used in western blot on human samples at 1:2000. Nucleic Acids Res (2014) ncbi
rabbit polyclonal
  • WB; human
EMD Millipore p53 antibody (Millipore, 06-916) was used in western blot on human samples. J Biol Chem (2014) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:500
In order to study the relationship between tumor protein D52 and ATM protein, EMD Millipore p53 antibody (Calbiochem, DO-1) was used in western blot on human samples at 1:500. Cell Cycle (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
EMD Millipore p53 antibody (Calbiochem, DO-1) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
mouse monoclonal (DO-1)
  • IHC-P; human; 1:100
EMD Millipore p53 antibody (Calbiochem, clone DO-1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oral Dis (2014) ncbi
mouse monoclonal (DO-1)
  • IC; human
  • WB; human
EMD Millipore p53 antibody (Calbiochem, DO-1) was used in immunocytochemistry on human samples and in western blot on human samples. Oncogene (2014) ncbi
rabbit polyclonal
  • WB; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, EMD Millipore p53 antibody (Millipore, 06-916) was used in western blot on mouse samples. J Neurosci (2013) ncbi
mouse monoclonal (DO-1)
  • ChIP; human
EMD Millipore p53 antibody (Calbiochem, DO-1) was used in chromatin immunoprecipitation on human samples. Mol Cancer Res (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human
EMD Millipore p53 antibody (Calbiochem, Do-1) was used in western blot on human samples. PLoS ONE (2012) ncbi
mouse monoclonal
  • WB; human
In order to identify NPGPx as a novel responder to non-targeting siRNA-induced stress, EMD Millipore p53 antibody (CalBiochem, OP-03) was used in western blot on human samples. Nucleic Acids Res (2012) ncbi
not indicated
  • WB; human
Calbiochem anti-p53 was used to perform western blot in order to show the role of cyclin K and cyclin D1b in multiple myeloma.Mol Cancer (2010) ncbi
not indicated
  • WB; human
Calbiochem mouse anti-p53 antibody was used for western blot in order to investigate the role of Hsp70 inducing agents in the treatment of genetic diseases.PLoS Genet (2010) ncbi
not indicated
  • WB; human
Oncogene anti-p53 was used to perform western blot in order to show that autophagy is induced by stent-eluting drugs sirolimus and paclitaxel to suppress healing of the endothelium.Am J Pathol (2009) ncbi
not indicated
  • WB; human
Calbiochem anti-TP53 mouse antibody (1:100) was used to perform western blot in order to study how to modulate gene expression and develop new drugs by short chain fatty acid (SCFA) hexosamine molecules.J Med Chem (2009) ncbi
not indicated
  • WB; human
Oncogene antibodies directed against p53 were used in western blot to investigate the role of endothelin systems in the regulation of physiologic renal growth and development.J Korean Med Sci (2009) ncbi
not indicated
  • WB; human
Calbiochem anti-p53 antibody was used to perform Western blot in order to reveal oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.RNA (2009) ncbi
not indicated
  • WB; human
Calbiochem mouse mAb anti-p53 antibody was used for western blot in order to demonstrate that the copy numbers of centriole and centrosome were regulated by Orc1 in human cells.Science (2009) ncbi
not indicated
  • IP; human
Calbiochem sheep anti-p53 polyclonal antibody was used to perform immunoprecipitation in order to illustrate that the Bmi1 functions on neurons oxidative metabolism are associated with repression of p53 pro-oxidant activity.J Neurosci (2009) ncbi
not indicated
  • WB; human
Calbiochem p53 antibody was used in western blot in order to demonstrate that the deubiquitinating enzyme USP5 (isopeptidase T) can regulate the activity of p53J Biol Chem (2009) ncbi
not indicated
  • IP; human
Calbiochem anti-p53 antibody (DO-1) agarose beads were used in immunoprecipitation to study the effect of simian virus 40 large T antigen on genome integrity and DNA damage response.J Virol (2009) ncbi
not indicated
  • WB; human
Calbiochem mouse monoclonal anti-p53 (OP43) and anti-p53CTF (OP03) was used to perform western blot in order to show that p53-dependent premature senescence could be induced by repression of the SUMO-specific protease Senp1 in normal human fibroblasts.Aging Cell (2008) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:2000
  • WB; mouse; 1:2000
EMD Millipore p53 antibody (Oncogene, DO-1) was used in western blot on human samples at 1:2000 and on mouse samples at 1:2000. Cell Cycle (2008) ncbi
not indicated
  • WB; human
Calbiochem anti-p53 antibody was used in western blot to study the mechanism and effect of p53 activation by a potent and specific MDM2 antagonist (MI-43) in colon cancer.Mol Cancer Ther (2008) ncbi
not indicated
  • WB; human
Oncogene Research Products mouse monoclonal anti-p53 antibody (Ab-6) was used in western blot to study the role for the effect of human papillomavirus Type 16 E6 on NF-kappaB activation and cIAP-2 expression in protecting from apoptosis in primary human airway epithelial cells.J Virol (2006) ncbi
not indicated
  • WB; human
EMD Bioscience mouse monoclonal anti-p53 antibody (Ab-6) was used in western blot to study the interaction of DcR2 with p53 and the role for DcR2 in regulating chemosensitivity in human tumor cell lines.Cancer Res (2005) ncbi
not indicated
  • WB; human
  • IP; human
  • IC; human
Oncogene monoclonal anti-p53 Ab-2 antibody was used in western blot, immunoprecipitation, and immunocytochemistry to study the regulation of p53 abundance through glycogen synthase kinase 3-dependent phosphorylation of Mdm2Mol Cell Biol (2005) ncbi
not indicated
  • WB; human
  • IC; human
Oncogene anti-p53 (Ab-6) antibody was used in western blot and immunocytochemistry to investigate the induction of DNA damage checkpoint signal transduction by herpes simplex virus.J Biol Chem (2005) ncbi
not indicated
  • WB; human
Upstate p53 antibody was used in western blot to investigate the effect of chloramphenicol-induced mitochondrial stress on p21 expression and cell apoptosisJ Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IP; human
Oncogene Research monoclonal anti-p53 antibody (DO-1) was used in western blot and immunoprecipitation to study the biological function of protein kinase A catalytic subunit beta.J Biol Chem (2005) ncbi
not indicated
  • WB; human
Oncogene Science anti-p53 antibody DO-1 was used in human mesenchymal stem cells (hMSCs) and in western blot to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs).Mol Biol Cell (2005) ncbi
Abcam
mouse monoclonal
  • WB; human
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples. Neurobiol Aging (2015) ncbi
rabbit polyclonal
  • WB; mouse; fig 6a
In order to determine the functional role of HDAC1 and HDAC2 in an acute model of optic nerve injury, Abcam p53 antibody (abcam, ab61241) was used in western blot on mouse samples (fig 6a). ASN Neuro (2015) ncbi
rabbit polyclonal
  • WB (knockout); human; fig 6
  • WB (knockdown); human; fig 5
Abcam p53 antibody (Abcam, ab17990) was used in western blot (knockout) on human samples (fig 6) and in western blot (knockdown) on human samples (fig 5). Sci Rep (2015) ncbi
not indicated
  • IHC; human
Anti-Ki67 antibody was used for immunohistochemical staining, in order to study the mechanism by which MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy.elife (2015) ncbi
rabbit polyclonal
  • WB; rat
Abcam p53 antibody (Abcam, ab37318) was used in western blot on rat samples. World J Gastroenterol (2015) ncbi
rabbit polyclonal
  • WB; hamsters
Abcam p53 antibody (Abcam, ab61241) was used in western blot on hamsters samples. J Mol Neurosci (2015) ncbi
mouse monoclonal (DO-1)
  • WB; mouse; fig 5sd
Abcam p53 antibody (Abcam, Ab80645) was used in western blot on mouse samples (fig 5sd). Oncotarget (2014) ncbi
mouse monoclonal
  • WB; human
Abcam p53 antibody (Abcam, ab1101) was used in western blot on human samples. BMC Biotechnol (2014) ncbi
rabbit polyclonal
  • WB; human
Abcam p53 antibody (Abcam, ab38497) was used in western blot on human samples. elife (2014) ncbi
not indicated
  • WB; human
Abcam anti-p53 antibody was used to perform western blotting in order to study JMJD6 promotes colon carcinogenesis through negative regulation of p53.PLoS Biol (2014) ncbi
rabbit polyclonal
  • WB; human
In order to investigate the HPV-16 splicing and its effect on primary human keratinocytes, Abcam p53 antibody (Abcam, ab131442) was used in western blot on human samples. PLoS ONE (2013) ncbi
rabbit polyclonal
  • WB; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, Abcam p53 antibody (Abcam, ab61241) was used in western blot on mouse samples. J Neurosci (2013) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Abcam p53 antibody (Abcam, ab80645) was used in western blot on human samples at 1:1000. J Carcinog (2012) ncbi
mouse monoclonal (DO-1)
  • WB; human; 1:1000
Abcam p53 antibody (Abcam, ab80645) was used in western blot on human samples at 1:1000. Mol Cell Biol (2013) ncbi
not indicated
  • WB; human
Abcam p53 antibody was used for western blot in order to investigate the role of DBC1 in the regulation of SIRT1 activity and high-fat diet induced liver steatosis in mice.J Clin Invest (2010) ncbi
not indicated
  • IHC; human
Abcam rabbit anti-pp53 antibody was used to perform immunohistochemistry in order to study the function of the fixative in the immunohistochemical detection of phosphoproteins.J Histochem Cytochem (2009) ncbi
Active Motif
mouse monoclonal (DO1)
  • WB; human
p53 antibody was used for Western analysis in order to study the effect of Ataxia-telangiectasia mutated (ATM) depletion on cell migration and invasion in a cancer-promoting process.elife (2015) ncbi
mouse monoclonal (DO1)
  • ChIP; human
Active Motif p53 antibody (active motif, 39553) was used in chromatin immunoprecipitation on human samples. Oncogene (2015) ncbi
rabbit polyclonal
  • ChIP; human
Active Motif p53 antibody (Active Motif, 39334) was used in chromatin immunoprecipitation on human samples. Cell Cycle (2010) ncbi
BioLegend
mouse monoclonal (DO-7)
  • FC; human; fig 3
In order to assess a protocol for acquiring portal venous blood through endoscopic ultrasound, BioLegend p53 antibody (Biolegend, 645806) was used in flow cytometry on human samples (fig 3). Gastroenterology (2015) ncbi
mouse monoclonal (BP53-12)
  • WB; human; fig 1
BioLegend p53 antibody (Biolegend, 628201) was used in western blot on human samples (fig 1). Oncogenesis (2012) ncbi
LifeSpan Biosciences
mouse monoclonal (PAb 122)
  • WB; rat; fig 1
LifeSpan Biosciences p53 antibody (LSBio, LS-C63152) was used in western blot on rat samples (fig 1). PLoS ONE (2015) ncbi
Spring Bioscience Corp.
rabbit monoclonal (SP5)
  • WB; human; fig 1
Spring Bioscience Corp. p53 antibody (Spring, M3050) was used in western blot on human samples (fig 1). Cell Tissue Res (2014) ncbi
GeneTex
mouse monoclonal (D01)
  • WB; human
GeneTex p53 antibody (Genetex, GTX70214) was used in western blot on human samples. PLoS ONE (2014) ncbi
R and D Systems
rabbit polyclonal
  • WB; mouse; 1:1000
R and D Systems p53 antibody (R&D Systems, AF-1043) was used in western blot on mouse samples at 1:1000. PLoS ONE (2014) ncbi
BioLogo
mouse monoclonal (DO-7)
  • IHC-P; human
BioLogo p53 antibody (BioLogo, DO-7) was used in immunohistochemistry - paraffin section on human samples. PLoS ONE (2013) ncbi
not indicated
  • IHC; human
Biologo p53 antibody was used in immunohistochemistry in order to characterize proteins involved in cell cycle controlBMC Cancer (2008) ncbi
AbD Serotec (Bio-Rad)
not indicated
  • WB; human
Serotec polyclonal anti-p53 antibody (clone Pab 240) was used in protein from human prostate and in western blot to study the expression of EG-VEGF/PK1 and PK2 and their receptors (PK-R1 and PK-R2) in human prostate and their involvement in cancer.Endocrinology (2006) ncbi
Epitomics
not indicated
  • WB; human
Anti-Ki67 antibody was used for immunoblot analysis, in order to investigate the effect of inhibition of mutant EGFR in lung cancer cell on SOX2-FOXO6-dependent survival pathways.elife (2015) ncbi
Beckman Coulter
not indicated
  • IHC; human
Immunotech anti-p53 antibody was used to perform immunohistochemistry in order to show that the p53 signature and endometrial glandular dysplasia often present at the beginning of serous intraepithelial carcinoma.Mod Pathol (2009) ncbi
Cell Signaling Technology
rabbit polyclonal
  • WB; mouse; 1:1000; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling, 9284L) was used in western blot on mouse samples at 1:1000 (fig 5). J Med Chem (2016) ncbi
mouse monoclonal (1C12)
  • WB; mouse; 1:500
Cell Signaling Technology p53 antibody (Cell Signaling, 2524-clon 1C12) was used in western blot on mouse samples at 1:500. Mol Cell Biol (2015) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples. Mol Cancer Ther (2015) ncbi
rabbit polyclonal
  • WB; mouse; 1:5000
Cell Signaling Technology p53 antibody (Cell Signaling, 2521) was used in western blot on mouse samples at 1:5000. Mol Oncol (2015) ncbi
rabbit polyclonal
  • WB; human; 1:500; fig 2.e
Cell Signaling Technology p53 antibody (CellSignaling, 9284) was used in western blot on human samples at 1:500 (fig 2.e). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • WB; mouse; fig 6a
In order to determine the functional role of HDAC1 and HDAC2 in an acute model of optic nerve injury, Cell Signaling Technology p53 antibody (Cell Signaling, 2570) was used in western blot on mouse samples (fig 6a). ASN Neuro (2015) ncbi
rabbit polyclonal
  • IHC-P; mouse; fig 6b
In order to determine the functional role of HDAC1 and HDAC2 in an acute model of optic nerve injury, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in immunohistochemistry - paraffin section on mouse samples (fig 6b). ASN Neuro (2015) ncbi
rabbit polyclonal
  • WB; human; 1:500
In order to determine if miRNA that target Muc1 are protective against pancreatic cancer, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:500. Biochim Biophys Acta (2015) ncbi
not indicated
  • WB; human
Phospho-p53 antibody was used for Western analysis in order to study the effect of Ataxia-telangiectasia mutated (ATM) depletion on cell migration and invasion in a cancer-promoting process.elife (2015) ncbi
rabbit polyclonal
  • WB; human
In order to investigate the effect of PC4 on genome stability and DNA repair, Cell Signaling Technology p53 antibody (Cell signalling, 9284) was used in western blot on human samples. Oncogene (2016) ncbi
mouse monoclonal (1C12)
  • WB; human
  • IC; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples and in immunocytochemistry on human samples at 1:1000. Mol Cancer Ther (2015) ncbi
mouse monoclonal (16G8)
  • IC; human
  • WB; rat
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in immunocytochemistry on human samples and in western blot on rat samples. Toxicol Lett (2015) ncbi
mouse monoclonal (1C12)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on human samples. J Biol Chem (2015) ncbi
mouse monoclonal (1C12)
  • WB; mouse; fig s5
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (1C12)
  • WB (knockout); mouse; 1:2000; fig 2a
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot (knockout) on mouse samples at 1:2000 (fig 2a). PLoS ONE (2015) ncbi
rabbit polyclonal
  • WB; human; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples (fig 1). EMBO J (2015) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000. Toxicol Appl Pharmacol (2015) ncbi
mouse monoclonal (1C12)
  • WB; human; fig s4g
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on human samples (fig s4g). Nature (2015) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples. Int J Oncol (2015) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000. Mutat Res (2015) ncbi
not indicated
  • WB; human
Anti-phospho-P53 antibody was used for western blotting, in order to study the mechanism by which Cry1/2 protect genomic integrity.elife (2015) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284L) was used in western blot on mouse samples. J Cell Biol (2015) ncbi
mouse monoclonal (1C12)
  • IC; mouse
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell signaling, 1C12) was used in immunocytochemistry on mouse samples and in western blot on mouse samples. Cell Death Dis (2015) ncbi
rabbit monoclonal (7F5)
  • IHC; human; 1:200; fig 1
  • WB; human; 1:1000; fig 2
In order to demonstrate that the p53-R248Q mutant targets the proteasome activator REGgamma to promote endometrial cancer progression, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2527) was used in immunohistochemistry on human samples at 1:200 (fig 1) and in western blot on human samples at 1:1000 (fig 2). Cancer Lett (2015) ncbi
mouse monoclonal (1C12)
  • WB; mouse
In order to study the relationship between Rb and p53 in normal and tumor cells, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on mouse samples. Stem Cells (2015) ncbi
mouse monoclonal (16G8)
  • WB; human
In order to identify the role of IFI27 in the cell proliferation of human epidermal keratinocytes, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples. Cell Prolif (2015) ncbi
mouse monoclonal (1C12)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, #2524) was used in western blot on human samples. Cell Death Differ (2015) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284 s) was used in western blot on human samples at 1:1000. Free Radic Biol Med (2015) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples. Oncotarget (2014) ncbi
rabbit polyclonal
  • WB; mouse; fig 5
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples (fig 5). Cell Death Dis (2014) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples. Cancer Res (2014) ncbi
rabbit polyclonal
  • WB; human; 1:1000; tbl 1
Cell Signaling Technology p53 antibody (Cell Signaling, 2570) was used in western blot on human samples at 1:1000 (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (1C12)
  • WB; human; 1:1000; tbl 1
Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (tbl 1). Methods Mol Biol (2015) ncbi
rabbit polyclonal
  • WB; human; 1:1000; tbl 1
Cell Signaling Technology p53 antibody (Cell Signaling, 9281) was used in western blot on human samples at 1:1000 (tbl 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (16G8)
  • WB; human; fig 3
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples (fig 3). Oncogene (2015) ncbi
mouse monoclonal (1C12)
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2524) was used in western blot on mouse samples. Biochim Biophys Acta (2015) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples. Biochim Biophys Acta (2015) ncbi
rabbit monoclonal (7F5)
  • IC; human
In order to identify and characterize several p53-activating small molecules, Cell Signaling Technology p53 antibody (Cell Signaling Technologies, 7F5) was used in immunocytochemistry on human samples. Mol Cancer Ther (2014) ncbi
mouse monoclonal (1C12)
  • WB; human
Cell Signaling Technology p53 antibody (cell signaling technology, 2524) was used in western blot on human samples. Oncotarget (2014) ncbi
mouse monoclonal (1C12)
  • WB; rat; 1:1000
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in western blot on rat samples at 1:1000. Neurosci Lett (2014) ncbi
rabbit polyclonal
  • WB; rat; 1:1000
Cell Signaling Technology p53 antibody (Cell Signalling, 9284) was used in western blot on rat samples at 1:1000. Neurosci Lett (2014) ncbi
mouse monoclonal (16G8)
  • WB; human; fig 1
In order to study the effect of ceramide treatment on p53, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286S) was used in western blot on human samples (fig 1). Biochim Biophys Acta (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples. Cancer Res (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples. J Biol Chem (2014) ncbi
rabbit polyclonal
  • WB; human
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples and on mouse samples. Oncogene (2015) ncbi
rabbit polyclonal
  • WB; rat; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on rat samples at 1:1000. Exp Gerontol (2014) ncbi
rabbit polyclonal
  • WB; human
  • WB; mouse
  • WB; rat
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples, on mouse samples, and on rat samples. J Neurosci (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 2526) was used in western blot on human samples. elife (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples. elife (2014) ncbi
rabbit polyclonal
  • WB; human
In order to explore DNA repair responses in human pluripotent stem cells, Cell Signaling Technology p53 antibody (Cell signaling, 9284) was used in western blot on human samples. J Biol Chem (2014) ncbi
rabbit polyclonal
  • WB; human; fig 1a
  • WB; mouse; fig 1b
Cell Signaling Technology p53 antibody (Cell signalling, 2525) was used in western blot on human samples (fig 1a) and on mouse samples (fig 1b). Am J Cancer Res (2014) ncbi
mouse monoclonal (1C12)
  • WB; mouse
In order to study p65-dependent NF-kapaB signaling in keratinocytes and its contribution to skin carcinogenesis, Cell Signaling Technology p53 antibody (Cell signalling, 2524) was used in western blot on mouse samples. EMBO Mol Med (2014) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples. J Neurosci (2014) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2570) was used in western blot on mouse samples. J Neurosci (2014) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2015) was used in western blot on human samples at 1:1000. Oncol Rep (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples. Cell Death Dis (2014) ncbi
rabbit polyclonal
  • WB; human; fig 1
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples (fig 1). Cell Tissue Res (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples. Oncogene (2014) ncbi
mouse monoclonal (1C12)
  • IC; cow; 1:100
In order to elucidate the acquired motility and invasiveness of T. annulata-infected cells, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in immunocytochemistry on cow samples at 1:100. PLoS Pathog (2014) ncbi
mouse monoclonal (1C12)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on human samples. PLoS ONE (2014) ncbi
mouse monoclonal (1C12)
  • WB; human; 1:1000; fig 3c
In order to study the role of a p53-miRNA-34 positive-feedback loop in tumor suppression in lung cancer, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on human samples at 1:1000 (fig 3c). Genes Dev (2014) ncbi
mouse monoclonal (1C12)
  • WB; mouse; fig 6a
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, Cell Signaling Technology p53 antibody (Cell Signaling, 2524) was used in western blot on mouse samples (fig 6a). PLoS ONE (2014) ncbi
rabbit polyclonal
  • WB; rat; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on rat samples at 1:1000. Biochim Biophys Acta (2014) ncbi
rabbit polyclonal
  • IHC-P; human
  • WB; human
In order to study the relationship between USP2-MDM4 and p53 in tumorigenesis, Cell Signaling Technology p53 antibody (Cell Signaling, 2521) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples. Carcinogenesis (2014) ncbi
rabbit polyclonal
  • WB; mouse; fig 2d
In order to elucidate how parvovirus minute virus of mice halts the cell cycle, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples (fig 2d). PLoS Pathog (2014) ncbi
mouse monoclonal (1C12)
  • WB; mouse
In order to study the mechanism for 2-hydroxyethyl methacrylate-induced apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling, 1C12) was used in western blot on mouse samples. Biomaterials (2014) ncbi
rabbit polyclonal
  • WB; mouse
In order to study the mechanism for 2-hydroxyethyl methacrylate-induced apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples. Biomaterials (2014) ncbi
rabbit polyclonal
  • WB; mouse; 1:10000; fig 2b
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on mouse samples at 1:10000 (fig 2b). J Biol Chem (2014) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 16G8) was used in western blot on human samples. J Biol Chem (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2525) was used in western blot on human samples. J Biol Chem (2014) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9287) was used in western blot on human samples. J Biol Chem (2014) ncbi
mouse monoclonal (1C12)
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 2524s) was used in western blot on mouse samples. Eur J Pharmacol (2014) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 9284s) was used in western blot on mouse samples. Eur J Pharmacol (2014) ncbi
mouse monoclonal (1C12)
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples at 1:1000. Endocrinology (2014) ncbi
rabbit polyclonal
  • WB; human; 1:500
In order to investigate the signaling events in pregnant and postnatal uteri of mice and baboons, Cell Signaling Technology p53 antibody (Cell Signaling Technologies, 9284) was used in western blot on human samples at 1:500. Endocrinology (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples. Cell Cycle (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples. PLoS ONE (2013) ncbi
mouse monoclonal (1C12)
  • WB; mouse; fig 3
Cell Signaling Technology p53 antibody (Cell Signalling, 1C12) was used in western blot on mouse samples (fig 3). Oncogene (2014) ncbi
mouse monoclonal (1C12)
  • WB; human; 1:1000
In order to study the relationship between tumor protein D52 and ATM protein, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 1C12) was used in western blot on human samples at 1:1000. Cell Cycle (2013) ncbi
mouse monoclonal (16G8)
  • WB; human; 1:1000
In order to study the relationship between tumor protein D52 and ATM protein, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 16G8) was used in western blot on human samples at 1:1000. Cell Cycle (2013) ncbi
mouse monoclonal (1C12)
  • IHC-F; mouse
  • WB; human
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 2524s) was used in immunohistochemistry - frozen section on mouse samples and in western blot on human samples and on mouse samples. J Am Heart Assoc (2013) ncbi
rabbit polyclonal
  • IHC-F; mouse
  • WB; human
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 9284s) was used in immunohistochemistry - frozen section on mouse samples and in western blot on human samples and on mouse samples. J Am Heart Assoc (2013) ncbi
rabbit polyclonalCell Signaling Technology p53 antibody (Cell Signaling Technology, 2525) was used . PLoS ONE (2013) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2525) was used in western blot on human samples at 1:1000. Cell Death Dis (2013) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9287) was used in western blot on human samples at 1:1000. Cell Death Dis (2013) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples. PLoS ONE (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9281) was used in western blot on human samples. PLoS ONE (2013) ncbi
rabbit polyclonal
  • WB; human
  • WB; mouse
  • IC; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples and on mouse samples and in immunocytochemistry on mouse samples. J Neurosci (2013) ncbi
rabbit polyclonal
  • WB; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, Cell Signaling Technology p53 antibody (Cell Signaling, 2570) was used in western blot on mouse samples. J Neurosci (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 2525) was used in western blot on human samples. Invest Ophthalmol Vis Sci (2013) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 2570) was used in western blot on mouse samples. Invest Ophthalmol Vis Sci (2013) ncbi
rabbit polyclonal
  • WB; mouse; 1:800
Cell Signaling Technology p53 antibody (Cell Signaling, 9287) was used in western blot on mouse samples at 1:800. Eur J Immunol (2013) ncbi
rabbit polyclonal
  • WB; mouse; 1:800
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:800. Eur J Immunol (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2525) was used in western blot on human samples. Mol Cell Biol (2013) ncbi
rabbit polyclonal
  • WB; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:1000. J Biol Chem (2013) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signalling, 9284) was used in western blot on human samples at 1:1000. Oncogene (2014) ncbi
rabbit polyclonal
  • WB; human
  • IC; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples and in immunocytochemistry on human samples. Cell Rep (2012) ncbi
mouse monoclonal (16G8)
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9286) was used in western blot on human samples. Radiat Res (2013) ncbi
mouse monoclonal (16G8)
  • WB; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in western blot on mouse samples at 1:1000. Cell Rep (2012) ncbi
rabbit polyclonal
  • WB; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:1000. Cell Rep (2012) ncbi
rabbit polyclonal
  • IHC-P; mouse; 1:200
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Zygote (2014) ncbi
rabbit polyclonal
  • WB; mouse; 1:200
Cell Signaling Technology p53 antibody (Cell Signaling, 9284S) was used in western blot on mouse samples at 1:200. Nat Med (2012) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples. Dev Biol (2013) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples. Cell Cycle (2012) ncbi
rabbit polyclonal
  • WB; human; 1:2000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:2000. Exp Hematol (2012) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot on human samples. Stem Cells (2012) ncbi
not indicated
  • WB; human
Cell Signaling anti-phospho-p53 (Ser20) antibody was used to perform western blot in order to show that p53-dependent cell proliferation and survival could be regulated by atg7.Science (2012) ncbi
not indicated
  • WB; human
Cell Signaling Technologies anti-p53K373ac was used to perform western blot in order to study the role of p53 in the differentiation of human embryonic stem cells.PLoS Biol (2012) ncbi
not indicated
  • IC; human
Cell Signaling anti-phospho-S15-p53 was used to perform immunocytochemistry in order to show that chromosomal structural aberrations could be caused by chromosome segregation errors.Science (2011) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples. J Ethnopharmacol (2011) ncbi
rabbit polyclonal
  • WB (knockout); mouse; fig 4a
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 9284) was used in western blot (knockout) on mouse samples (fig 4a). Mamm Genome (2011) ncbi
rabbit polyclonal
  • WB; human; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on human samples at 1:1000. Nucleic Acids Res (2011) ncbi
not indicated
  • WB; human
Cell Signaling phospho-p53 antibody (Ser15) was used to perform western blot in order to clarify that Skp2 involved in the p19Arf-p53 pathway independent cellular senescence.Nature (2010) ncbi
not indicated
  • IHC; human
Cell Signaling Technology p-S15-p5 antibody was used in immunohistochemistry in order to show the importance of protection of the ATM-mediated DDR-p53 signaling pathway for breast cancer prevention.Proc Natl Acad Sci U S A (2010) ncbi
rabbit polyclonal
  • WB; mouse
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples. J Biol Chem (2010) ncbi
  • WB; human
Cell Signaling anti-p53 antibody was used for western blot in order to investigate the role for activated Bax in the regulation of p53-dependent, transcription-independent neural precursor cell apoptosis.J Histochem Cytochem (2010) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling Technology, 2521) was used in western blot on human samples. J Mol Endocrinol (2010) ncbi
not indicated
  • WB; human
Cell Signaling total p53 antibody was used to perform western blot in order to investigate the relations between SGI-1776 and chronic lymphocytic leukemiaBlood (2009) ncbi
not indicated
  • WB; human
Cell Signaling Technology anti-p53 antibody was used as primary antibody for immunoblotting in order to suggest that ATM plays a role in oncogene-induced senescence or in p53-dependent tumor suppression.PLoS ONE (2009) ncbi
not indicatedCell Signaling p53 was used in immunoblot to analyze the proteins extracted from cells in order to identify p27Kip1 and Patched-1 can prevent medulloblastoma.Mol Cancer Res (2009) ncbi
not indicated
  • WB; human
Cell Signaling Technologies p53 antibody was used in western blot in order to study the effect of MDM2-dependent inhibition of p53 on EBV growth transformation of B-cell and infected-cell survival.J Virol (2009) ncbi
not indicated
  • WB; human
Cell Signaling p53 antibody was used in western blot in order to determine the effect of HMGN1 for ATM activation by regulating the levels of histone modifications.Nat Cell Biol (2009) ncbi
not indicated
  • WB; human
Cell Signaling rabbit polyclonal anti-p53 antibody was used to detect p53 in western blot in order to demonstrate that the MAPK/CREB cascade and the STAT-3 signaling pathway mediate H-IL-6-activated neurogenesis and gliogenesisMol Biol Cell (2009) ncbi
not indicated
  • WB; human
Cell Signaling anti-P-p53 S15 and anti-P-p53 S20 antibodies were used in western blot in order to study the role of TRAIL for activation of DNA damage response pathways with histone H2AX and Chk2 phosphorylations.Mol Cell Biol (2009) ncbi
not indicated
  • WB; human
Cell Signaling anti-phospho-p53 antibody (phospho-p53 antibody sampler kit) was used in western blot to study the effect of simian virus 40 large T antigen on genome integrity and DNA damage response.J Virol (2009) ncbi
  • WB; human
Cell Signaling Technology anti-phospho-p53 antibody was used in western blot to study the mechanism and effect of p53 activation by a potent and specific MDM2 antagonist (MI-43) in colon cancer.Mol Cancer Ther (2008) ncbi
not indicated
  • WB; human
Cell Signaling Technology polyclonal rabbit p53S15P antibody was used in western blot in order to demonstrate that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitroPLoS ONE (2008) ncbi
not indicated
  • WB; human
Cell Signaling Technology polyclonal rabbit p53S46P antibody was used in western blot in order to demonstrate that ATM undergoes an activating phosphorylation in syncytia elicited by the envelope glycoprotein complex (Env) of human immunodeficiency virus-1 (HIV-1) in vitroPLoS ONE (2008) ncbi
not indicated
  • IHC; human
Cell Signaling Technology p53 antibody was used in immunohistochemistry in order to study the molecular basis of the mutant-specific manifestation of age-related phenotypesPLoS ONE (2008) ncbi
not indicated
  • WB; human
Cell Signaling anti-phospho-p53 (Ser15) antibody and anti-p53 antibody were used in western blot to study the role for saturated fatty acids in DNA damage response.PLoS ONE (2008) ncbi
not indicated
  • IHC; human
Cell Signaling anti-phospho p53 antibody was used in immunohistochemistry in order to show in vivo accumulation of cells without extremes in enrichment or modification of many of the DDR proteins related to senescenceMech Ageing Dev (2008) ncbi
not indicated
  • WB; human
Cell Signaling Technology anti-p53 antibody was used to perform western blot in order to study how genistein regulate tumor suppressor genes in prostate cancer cells.Int J Cancer (2008) ncbi
  • WB; human
Cell Signaling Technology TP53 antibody was used in western blot in order to study the antiapoptotic role of PXR in colon cancerMol Endocrinol (2008) ncbi
not indicated
  • WB; human
Cell Signaling anti-phospho-p53 antibody was used to perform western blot in order to study the contribution of hSRBC epigenetic inactivation to the malignant progression in gastric cancer through attenuated p53 response to stresses.Int J Cancer (2008) ncbi
not indicated
  • WB; human
Cell Signaling-technology anti-acetylated-p53 antibody was used in western blot to study the molecular mechanisms of BAF53 in regulating p53-mediated gene transcription.J Biochem (2007) ncbi
not indicated
  • WB; human
Cell Signaling Technology phospho-p53 (Ser-15) antibody was used in western blot to report an increase in S100A6 protein level in colon and lung cancer cells postexposure to ionizing radiation.Mol Cell Proteomics (2007) ncbi
not indicated
  • WB; human
Cell Signaling anti-phospho-p53 antibody was used in western blot to identify p18 (Hamlet) as a new cell-fate regulator.EMBO J (2007) ncbi
rabbit polyclonal
  • WB; human
Cell Signaling Technology p53 antibody (Cell Signaling, #9284) was used in western blot on human samples. FEBS Lett (2006) ncbi
mouse monoclonal (16G8)
  • IHC; mouse
In order to examine the neuronal cell death in the spinal cords of mSOD1 and wtSOD1 mice, Cell Signaling Technology p53 antibody (Cell Signaling, 9286) was used in immunohistochemistry on mouse samples. J Comp Neurol (2007) ncbi
rabbit polyclonal
  • WB; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9282) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2006) ncbi
rabbit polyclonal
  • WB; mouse; 1:1000
Cell Signaling Technology p53 antibody (Cell Signaling, 9284) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2006) ncbi
not indicated
  • WB; human
  • IHC; human
Cell Signaling anti-phospho-p53 Ser15 antibody was used in western blot and immunohistochemistry to study the down-regulation of constitutive and UVB-induced COX-2 levels by T-oligo treatment through p53- and NFkappaB-dependent repression of the COX-2 promoter.J Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IC; human
Cell Signaling anti-phospho-p53 (Ser-15) antibody was used in western blot and immunocytochemistry to investigate the induction of DNA damage checkpoint signal transduction by herpes simplex virus.J Biol Chem (2005) ncbi
not indicated
  • WB; human
Cell Signaling anti-p53 antibody was used in western blot to investigate the role of ORC2 in CDK2 activationJ Biol Chem (2005) ncbi
not indicated
  • WB; human
Cell Signaling Technology phospho-p53 antibody was used in western blot to study the effect of human p53 serine 46 phosphorylation on promoter selection and apoptosisJ Biol Chem (2005) ncbi
not indicated
  • WB; human
Cell Signaling Technology anti-phospho-p53 (p-p53) (Ser15) antibody (9284) was used in human mesenchymal stem cells (hMSCs) and in western blot to study the prolongation of life span of human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs).Mol Biol Cell (2005) ncbi
Dako
mouse monoclonal (DO-7)
  • WB; human
Dako p53 antibody (Dako, M7001) was used in western blot on human samples. Mol Cancer Ther (2015) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:100
In order to investigate markers expressed by stromal cells in breast cancer patients, Dako p53 antibody (DakoCytomation, M7001) was used in immunohistochemistry on human samples at 1:100. Mol Clin Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:3000
In order to develop and characterize patient-derived primary xenografts to a model of muscle invasive bladder cancer, Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:3000. Oncotarget (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:80
Dako p53 antibody (Dako, clone DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:80. BMC Cancer (2015) ncbi
mouse monoclonal (DO-7)
  • IC; human; fig 2.
  • WB; human; fig 2.
Dako p53 antibody (DAKO, M7001) was used in immunocytochemistry on human samples (fig 2.) and in western blot on human samples (fig 2.). PLoS ONE (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:1500
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:1500. Ann Surg Oncol (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; rat; 1:150
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on rat samples at 1:150. Acta Cir Bras (2015) ncbi
mouse monoclonal (DO-7)
  • IC; human; fig s1
In order to explore how Tpr regulated chromosomal segregation, Dako p53 antibody (Dako, DO-7) was used in immunocytochemistry on human samples (fig s1). Cell Cycle (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human
Dako p53 antibody (DAKO, DO-7) was used in western blot on human samples. Mutat Res (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human
Dako p53 antibody (Dako, DO-7) was used in western blot on human samples. Oncotarget (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:50
In order to study the relationship between autophagy and anti-tumor immune responses using immunohistochemistry, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Cancer Sci (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:300
Dako p53 antibody (DAKOCytomation, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:300. Anticancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:700
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:700. Endocr Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • IC; human; 1:50
Dako p53 antibody (Dako, DO7) was used in immunocytochemistry on human samples at 1:50. Cell Stress Chaperones (2015) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:50
Dako p53 antibody (Dako, DO7) was used in immunohistochemistry on human samples at 1:50. Cancer Med (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human
In order to describe the histological features canalicular adenoma, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples. Head Neck Pathol (2015) ncbi
mouse monoclonal (DO-7)
  • IHC; mouse
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on mouse samples. Head Neck (2015) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:1000
In order to correlate 18-F-fluoro-deoxyglucose uptake and aggressive tumor biology in predicting outcome in esophageal cancer, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Ann Surg Oncol (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:100
Dako p53 antibody (DAKO, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:100. Biomed Res Int (2014) ncbi
rabbit monoclonal (318-6-11)
  • IHC-P; human; 1:50; fig 3
Dako p53 antibody (DAKO, 3629) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Cell Tissue Res (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:100
Dako p53 antibody (Dako, clone DO-7) was used in immunohistochemistry on human samples at 1:100. Oncol Lett (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:40000
In order to screen a panel of 33 proteins to establish a set of biomarkers that predict the agressiveness of prostate cancer, Dako p53 antibody (Dako, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:40000. BMC Cancer (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:50
In order to determine the immunohistochemical, ultrastructural and genetic features of a patient with tanycytic ependymoma and that has a heterozygous truncating mutation in the NF2 gene, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Neuropathology (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human
Dako p53 antibody (Dako Denmark, M-7001) was used in immunohistochemistry on human samples. ScientificWorldJournal (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:100
Dako p53 antibody (Dako, M 7001) was used in immunohistochemistry on human samples at 1:100. Anticancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:300
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:300. Cancer Res (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:1500
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on human samples at 1:1500. Hum Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human; 1:50
In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry on human samples at 1:50. Fetal Pediatr Pathol (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human
In order to study salivary duct carcinoma with rhabdoid features, Dako p53 antibody (DakoCytomation, DO-7) was used in immunohistochemistry on human samples. Head Neck (2014) ncbi
mouse monoclonal (DO-7)
  • IHC; human
In order to compare the diagnostic efficacies of cell block method and conventional smear method for bile cytology, Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry on human samples. Dig Endosc (2013) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:500
Dako p53 antibody (Dako, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:500. World Neurosurg (2014) ncbi
mouse monoclonal (DO-7)
  • WB; human
Dako p53 antibody (Dako, M 7001) was used in western blot on human samples. PLoS ONE (2013) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:300
Dako p53 antibody (DAKOCytomation, M7001) was used in immunohistochemistry - paraffin section on human samples at 1:300. Oncology (2013) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:2000
In order to report an example of an atypical prolactin-producing pituitary adenoma that shows clear morphologic and immunohistochemical evidence of neurocytic transformation, Dako p53 antibody (Dako, DO7) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Appl Immunohistochem Mol Morphol (2014) ncbi
not indicated
  • IHC; human
Dako monoclonal mouse anti-human P53 was used to perform immunohistochemistry in order to show that the relationship between expression and prognostic significance of Cox-2 and p-53 with Hodgkin lymphomas.Diagn Pathol (2010) ncbi
not indicated
  • IHC; human
Dako p53 antibody (clone: DO-7, 1/200 dilution) was used to perform immunohistochemistry in order to clarify that high CENP-F expression was the prognostic indicator of primary breast cancer.BMC Cancer (2008) ncbi
not indicated
  • IHC; human
DAKO monoclonal anti-p53 antibody (clone:DO-7) was used in immunohistochemistry to identify biomarkers in ductal carcinoma in situ of the breast with microinvasion in paraffin sections from human tumor.BMC Cancer (2008) ncbi
mouse monoclonal (DO-7)
  • IHC-P; human; 1:50
Dako p53 antibody (DAKO, DO-7) was used in immunohistochemistry - paraffin section on human samples at 1:50. Virchows Arch (2008) ncbi
not indicated
  • IHC; human
DAKO mouse monoclonal p53 antibody (1:100) was used in immunohistochemistry in order to investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancerBreast Cancer Res (2008) ncbi
not indicated
  • IHC; human
DAKO mouse anti-p53 antibody was used in immunohistochemistry to investigate the pathobiological behaviors of gastric mixed-type (MT) carcinomas and gastric carcinogenesis.Virchows Arch (2008) ncbi
not indicated
  • WB; human
  • IHC; human
Dako anti-p53 DO-7 antibody was used in western blot and immunohistochemistry to study the down-regulation of constitutive and UVB-induced COX-2 Levels by T-oligo treatment through p53- and NFB-dependent repression of the COX-2 promoterJ Biol Chem (2005) ncbi
not indicated
  • WB; human
DAKO p53-specific DO-7 monoclonal antibody was used in western blot to study the lck degradation and refractory state in CD8+ cytotoxic T lymphocytesProc Natl Acad Sci U S A (2005) ncbi
not indicated
  • WB; human
DAKO monoclonal anti-p53 antibody DO-7 was used in western blot to study the Np73-mediated transactivation of the BTG2TIS21/PC3 gene.J Cell Sci (2005) ncbi
not indicated
  • IHC; human
DAKOCytomation anti-p53 antibody was used in immunohistochemistry to study the association of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas.Mol Cell Proteomics (2005) ncbi
not indicated
  • IHC; human
DAKO antibody against p53 (Clone D07) was used in immunohistochemistry to investigate the distribution of p53 among different types and grades of human endometrial carcinomas.Mod Pathol (2005) ncbi
BD Biosciences
mouse monoclonal (DO-7)
  • FC; human
In order to discuss the role of CD47 modulation in treatment of chronic lymphocytic leukemia, BD Biosciences p53 antibody (BD Biosciences, DO-7) was used in flow cytometry on human samples. PLoS Med (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human; 1:500
In order to study the regulation of the human papillomavirus 16 oncoprotein expression, BD Biosciences p53 antibody (BD Pharmingen, DO-7) was used in western blot on human samples at 1:500. J Virol (2015) ncbi
mouse monoclonal (DO-1)
  • ChIP; human; fig 1
BD Biosciences p53 antibody (BD Pharmingen, DO-1) was used in chromatin immunoprecipitation on human samples (fig 1). Oncogene (2015) ncbi
mouse monoclonal (DO-7)
  • WB; human
BD Biosciences p53 antibody (BD, 554294) was used in western blot on human samples. Hum Mol Genet (2015) ncbi
mouse monoclonal (J159-641.79)
  • WB; human
BD Biosciences p53 antibody (BD, 560282) was used in western blot on human samples. Hum Mol Genet (2015) ncbi
mouse monoclonal (80/p53)
  • WB; human
BD Biosciences p53 antibody (BD Biosciences, 610183) was used in western blot on human samples. Biol Pharm Bull (2014) ncbi
mouse monoclonal (G59-12)
  • WB; rat; 1:1000
BD Biosciences p53 antibody (BD Pharmingen, 554157) was used in western blot on rat samples at 1:1000. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (G59-12)
  • WB; mouse; 1:500
In order to study the role of TGF-beta inhibitors in abolishing the resistance of glioblastoma to ionozing radiation therapy, BD Biosciences p53 antibody (BD Biosciences, 554157) was used in western blot on mouse samples at 1:500. Cancer Res (2012) ncbi
not indicated
  • WB; human
BD Pharmingen anti-p53 antibody was used to perform western blot in order to show that p53-dependent cell proliferation and survival could be regulated by atg7.Science (2012) ncbi
mouse monoclonal (DO-1)
  • WB; human
BD Biosciences p53 antibody (BD Pharmingen, 554293) was used in western blot on human samples. Cell Death Differ (2011) ncbi
mouse monoclonal (80/p53)
  • WB; human
BD Biosciences p53 antibody (BD Biosciences, 610183) was used in western blot on human samples. Int J Cancer (2011) ncbi
not indicated
  • WB; human
  • IC; human
BD PharMingen alpha-p53 atibody was used in western blot in order to identify p53 target genes using a genome-wide ChIP-on-chip studyNucleic Acids Res (2008) ncbi
not indicated
  • ChIP; human
BD PharMingen SDO1 antibody was used in ChIP assays in order to identify p53 target genes using a genome-wide ChIP-on-chip studyNucleic Acids Res (2008) ncbi
mouse monoclonal (DO-7)
  • WB; human
BD Biosciences p53 antibody (BD Biosciences, DO-7) was used in western blot on human samples. Cell Death Differ (2008) ncbi
not indicated
  • WB; human
BD PharMingen anti-p53 antibody was used in western blot to determine whether ATO could target AME and related oncoproteins.Cancer Res (2006) ncbi
not indicated
  • WB; human
BD Biosciences anti-p53 antibody and anti-phosphorylated p53 antibody were used in western blot to study the function of Frag1 protein in higher eukaryotes.Proc Natl Acad Sci U S A (2005) ncbi
Sigma-Aldrich
mouse monoclonal (DO-7)
  • WB; human
In order to determine if an imbalance exists in activities, mRNA, and protein expression of the antioxidant enzymes SOD1, SOD2, glutathione-peroxidase, and catalase in T21F cells, Sigma-Aldrich p53 antibody (Sigma-Aldrich, P8999) was used in western blot on human samples. Oxid Med Cell Longev (2015) ncbi
not indicated
  • WB; human
Sigma mouse anti-p53 monoclonal antibody was used in western blot to investigate the role of hypoxia in the regulation of human lung fibroblast proliferation.Respir Res (2009) ncbi
not indicated
  • WB; human
  • ChIP; human
Sigma mouse monoclonal anti-human p53 antibody was used in western blot and ChIP assays in order to demonstrate that annexin A1 promoter activity is controlled by a functional cooperation between p53 and factors binding to the proximal CCAAT boxMol Cell Biol (2008) ncbi
MBL International
not indicated
  • IP; human
MBL anti-p53 antibody was used to perform western blotting in order to study JMJD6 promotes colon carcinogenesis through negative regulation of p53.PLoS Biol (2014) ncbi
Abgent
not indicated
  • WB; human
Abgent p53 antibody was used in western blot to study the role of USP2a in the p53 pathway.EMBO J (2007) ncbi
Individual Researcher
not indicated
  • WB; human
P53 antibody from Dr. Frederick E. Domann lab was used in western blot in order to demonstrate that inhibitors of glucose and hydroperoxide metabolism can be used in combination with Adp53 gene therapy to enhance cell killing in human prostate cancer cellsFree Radic Biol Med (2008) ncbi
GE Healthcare Life Biosciences
not indicatedDharmacon p53 siRNA was used to perform Luciferase assay in order to show that chromosomal structural aberrations could be caused by chromosome segregation errors.Science (2011) ncbi
Vector Laboratories
not indicated
  • WB; human
Vector Laboratories anti-p53 antibody was used in western blot in order to investigate the mechanism of how the embryonic stem cells chromatin structure change was regulated by condensin complexes during mitotic progression.J Cell Biol (2010) ncbi
not indicated
  • IHC; human
Vector Laboratories anti-p53 was used to perform immunohistochemistry in order to show the different DNA damage signalings between A-T-like disease and Nijmegen breakage syndrome.Genes Dev (2009) ncbi
Leica Biosystems
not indicated
  • WB; human
Novocastra p53 antibody was used to perform western blot in order to clarify that Skp2 involved in the p19Arf-p53 pathway independent cellular senescence.Nature (2010) ncbi
not indicated
  • IHC; human
Novocastra p53 antibody was used in immunohistochemistry in order to show the importance of protection of the ATM-mediated DDR-p53 signaling pathway for breast cancer prevention.Proc Natl Acad Sci U S A (2010) ncbi
not indicated
  • IHC; human
Novocastra anti-p53 antibody was used for immunohistochemistry to incubate the tumor samples in order to suggest that ATM plays a role in oncogene-induced senescence or in p53-dependent tumor suppression.PLoS ONE (2009) ncbi
not indicated
  • WB; human
Novocastra anti-p53 antibody was used to perform western blot in order to show that the loss of Faf1 resulted in aberrant NF-kB signaling and tumor progression.Proc Natl Acad Sci U S A (2009) ncbi
not indicated
  • IHC; human
Novocastra Laboratories mouse monoclonal p53 antibody was used in immunohistochemistry at 1:20 in order to evaluate the prognostic significance of apoptosis-related proteins p53, Bax, and galectin-3 in patients with non-small cell lung cancer (NSCLC) treated with surgical resectionJpn J Clin Oncol (2008) ncbi
not indicated
  • WB; human
Novocastra antibody against p53 (NCL-p53-505) was used in western blot to detect p53 in mouse embryo fibroblasts (MEFs).Genes Dev (2008) ncbi
not indicated
  • WB; human
Novocastra antibody which recognizes human p53 was used in western blot to study that p400 is required for E1A to promote apoptosis.J Biol Chem (2005) ncbi
Articles Reviewed
  1. Jaeki Min et al. (2016). "Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents".PMID 26632965
  2. Daniel V T Catenacci et al. (2015). "Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound".PMID 26341722
  3. Lingling Cao et al. (2015). "Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability".PMID 26340092
  4. Kee Chan Ahn et al. (2015). "Inhibition of p53 attenuates ischemic stress-induced activation of astrocytes".PMID 26302161
  5. Bo Tan et al. (2015). "RNF4 negatively regulates NF-κB signaling by down-regulating TAB2".PMID 26299341
  6. Alejandra González-Loyola et al. (2015). "Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development".PMID 26240282
  7. Zhihua Zhang et al. (2015). "NR2B-dependent cyclophilin D translocation suppresses the recovery of synaptic transmission after oxygen-glucose deprivation".PMID 26232180
  8. Kyoung Wan Yoon et al. (2015). "Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53".PMID 26228159
  9. Shinichi Kiyonari et al. (2015). "The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis".PMID 26208523
  10. Mariangela Succoio et al. (2015). "Proteomic analysis reveals novel common genes modulated in both replicative and stress-induced senescence".PMID 26206181
  11. Maik Dahlhoff et al. (2015). "ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis".PMID 26194695
  12. Mi Li et al. (2015). "The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism".PMID 26174856
  13. Vasundhara Sharma et al. (2015). "Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay".PMID 26147604
  14. Rémi Martin Laberge et al. (2015). "MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation".PMID 26147250
  15. Rui Liu et al. (2015). "CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance".PMID 26141949
  16. Fiorita Gonzales Lopes Mundim et al. (2015). "MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases".PMID 26137258
  17. Fr d ric Lebrun-Julien et al. (2015). "Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression".PMID 26129908
  18. S Jacquin et al. (2015). "Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats".PMID 26121334
  19. M Marchesini et al. (2015). "PML is required for telomere stability in non-neoplastic human cells".PMID 26119943
  20. Makoto T Hayashi et al. (2015). "Cell death during crisis is mediated by mitotic telomere deprotection".PMID 26108857
  21. Adam Pickard et al. (2015). "HPV16 Down-Regulates the Insulin-Like Growth Factor Binding Protein 2 to Promote Epithelial Invasion in Organotypic Cultures".PMID 26107517
  22. Jing Zhao et al. (2015). "Death-associated protein kinase 1 promotes growth of p53-mutant cancers".PMID 26075823
  23. Natalia Rueda-Rincon et al. (2015). "p53 attenuates AKT signaling by modulating membrane phospholipid composition".PMID 26061814
  24. Shu Hui Neo et al. (2015). "TRIM28 Is an E3 Ligase for ARF-Mediated NPM1/B23 SUMOylation That Represses Centrosome Amplification".PMID 26055329
  25. Wolfgang Jäger et al. (2015). "Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies".PMID 26041878
  26. Shi Yun Chen et al. (2016). "Glioneuronal tumours with features of rosette-forming glioneuronal tumours of the fourth ventricle and dysembryoplastic neuroepithelial tumours: a report of three cases".PMID 26040650
  27. Solange Tréhoux et al. (2015). "Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells".PMID 26036346
  28. Jieun Yun et al. (2015). "p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1".PMID 26033683
  29. Wei Ta Chen et al. (2015). "ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion".PMID 26030852
  30. Olga Moiseeva et al. (2015). "Mutant lamin A links prophase to a p53 independent senescence program".PMID 26029982
  31. B Chen et al. (2015). "N-myc downstream-regulated gene 1 (NDRG1) mediates pomegranate juice protection from apoptosis in hypoxic BeWo cells but not in primary human trophoblasts".PMID 26028238
  32. Robin K Bishop et al. (2015). "Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells".PMID 26023679
  33. Varsha Tembe et al. (2015). "The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function".PMID 26022179
  34. Chuan Pin Yang et al. (2015). "Identification and characterization of nuclear and nucleolar localization signals in 58-kDa microspherule protein (MSP58)".PMID 25981436
  35. O Mortusewicz et al. (2016). "PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites".PMID 25961912
  36. Ye Li et al. (2015). "{2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic Acid Methyl Ester Inhibited Hepatocellular Carcinoma Growth in Bel-7402 Cells and Its Resistant Variants by Activation of NOX4 and SIRT3".PMID 25961022
  37. Vanessa Andries et al. (2015). "NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest".PMID 25958384
  38. Bernhard Robl et al. (2015). "Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy".PMID 25956431
  39. Alicia M Waters et al. (2015). "Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma".PMID 25944918
  40. Li Zhang et al. (2015). "FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells".PMID 25939952
  41. Alok Mishra et al. (2015). "Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer".PMID 25932049
  42. Jordan Wright et al. (2015). "The Human Adenovirus Type 5 L4 Promoter Is Negatively Regulated by TFII-I and L4-33K".PMID 25926634
  43. Marybeth Sechler et al. (2015). "Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)".PMID 25925948
  44. Tadamoto Isogai et al. (2015). "SMIFH2 has effects on Formins and p53 that perturb the cell cytoskeleton".PMID 25925024
  45. Fabiana Salm et al. (2015). "The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma".PMID 25915540
  46. Duygu Kankaya et al. (2015). "Gelsolin, NF-κB, and p53 expression in clear cell renal cell carcinoma: Impact on outcome".PMID 25908108
  47. Claudia Cattoglio et al. (2015). "Functional and mechanistic studies of XPC DNA-repair complex as transcriptional coactivator in embryonic stem cells".PMID 25901318
  48. Moushumi Suryavanshi et al. (2015). "Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression: An Indian outlook".PMID 25899828
  49. Takayuki Seiki et al. (2015). "HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1γ in cervical malignancy".PMID 25886518
  50. Leanne G Ahronian et al. (2015). "The p53R172H mutant does not enhance hepatocellular carcinoma development and progression".PMID 25885474
  51. Kaitlen Samse et al. (2015). "Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells".PMID 25882843
  52. Lauren A Gillory et al. (2015). "Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival".PMID 25862488
  53. Peggy Prickaerts et al. (2015). "MK3 modulation affects BMI1-dependent and independent cell cycle check-points".PMID 25853770
  54. Victor Rodríguez-Sureda et al. (2015). "Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21".PMID 25852816
  55. Jitendra K Meena et al. (2015). "Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion".PMID 25820263
  56. Sara Ortega-Atienza et al. (2015). "Proteasome activity is important for replication recovery, CHK1 phosphorylation and prevention of G2 arrest after low-dose formaldehyde".PMID 25817892
  57. Patrick L Leslie et al. (2015). "The MDM2 RING domain and central acidic domain play distinct roles in MDM2 protein homodimerization and MDM2-MDMX protein heterodimerization".PMID 25809483
  58. Enni Markkanen et al. (2015). "Cells deficient in base-excision repair reveal cancer hallmarks originating from adjustments to genetic instability".PMID 25800737
  59. Zhengshan Chen et al. (2015). "Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia".PMID 25799995
  60. Changhoon Yoo et al. (2015). "Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib".PMID 25791792
  61. Karla Luciana Magnani et al. (2015). "Respiratory immunohistochemical study in rats exposed to cigarette smoke and alcohol".PMID 25790005
  62. Akiko Kobayashi et al. (2015). "Therapeutic potential of mitotic interaction between the nucleoporin Tpr and aurora kinase A".PMID 25789545
  63. Yifei Wang et al. (2015). "The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells".PMID 25776829
  64. Chinthalapally V Rao et al. (2015). "Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model".PMID 25773652
  65. Yvette P Geels et al. (2015). "Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium".PMID 25773202
  66. Susanna Ambrosio et al. (2015). "MYC impairs resolution of site-specific DNA double-strand breaks repair".PMID 25770827
  67. Bing Yen Wang et al. (2015). "Benzo[a]pyrene-induced cell cycle progression occurs via ERK-induced Chk1 pathway activation in human lung cancer cells".PMID 25769181
  68. John N Griffin et al. (2015). "The ribosome biogenesis factor Nol11 is required for optimal rDNA transcription and craniofacial development in Xenopus".PMID 25756904
  69. Stephanie J Papp et al. (2015). "DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization".PMID 25756610
  70. Ana Carolina Martinez-Torres et al. (2015). "CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans".PMID 25734483
  71. Jianhua Xiong et al. (2015). "Stemness factor Sall4 is required for DNA damage response in embryonic stem cells".PMID 25733712
  72. Patrick Ehm et al. (2015). "The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies".PMID 25723258
  73. H Yan et al. (2015). "p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53".PMID 25719246
  74. Melanie McFarlane et al. (2015). "Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35)".PMID 25717103
  75. Amanda L Balboni et al. (2015). "p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals".PMID 25700283
  76. Sembulingam Tamilzhalagan et al. (2015). "Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer".PMID 25697906
  77. Huihui Wang et al. (2015). "Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ".PMID 25697482
  78. Shunsuke Kitajima et al. (2015). "Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts".PMID 25694388
  79. Yongjie Wei et al. (2015). "The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation".PMID 25693418
  80. S Michael Rothenberg et al. (2015). "Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways".PMID 25686219
  81. Eirini Pantazi et al. (2015). "Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach".PMID 25684941
  82. Michiel Simons et al. (2015). "A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases".PMID 25675183
  83. W L Hsieh et al. (2015). "IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes".PMID 25664647
  84. J S Long et al. (2015). "p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death".PMID 25659586
  85. Johnny Loke et al. (2015). "Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway".PMID 25652403
  86. Rajakishore Mishra et al. (2015). "Expression and inactivation of glycogen synthase kinase 3 alpha/ beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression".PMID 25645517
  87. Anna Lewinska et al. (2015). "Curcumin induces oxidation-dependent cell cycle arrest mediated by SIRT7 inhibition of rDNA transcription in human aortic smooth muscle cells".PMID 25644192
  88. Shu Lin Xian et al. (2015). "3-Bromopyruvate inhibits human gastric cancer tumor growth in nude mice via the inhibition of glycolysis".PMID 25621044
  89. Marcos Villar Laura et al. (2015). "KSHV latent protein LANA2 inhibits sumo2 modification of p53".PMID 25607652
  90. Ailine Stolz et al. (2015). "A phenotypic screen identifies microtubule plus end assembly regulators that can function in mitotic spindle orientation".PMID 25590964
  91. Xiuhua Zhao et al. (2015). "Spontaneous immortalization of mouse liver sinusoidal endothelial cells".PMID 25585915
  92. Sylvia F Boj et al. (2015). "Organoid models of human and mouse ductal pancreatic cancer".PMID 25557080
  93. Simona Gurzu et al. (2015). "Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity".PMID 25556597
  94. Arman Ghorbani et al. (2015). "PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells".PMID 25524737
  95. Yunlong He et al. (2015). "p53 loss increases the osteogenic differentiation of bone marrow stromal cells".PMID 25524638
  96. Zhen Li et al. (2015). "p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma".PMID 25512615
  97. Chen Shao et al. (2015). "Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer".PMID 25505174
  98. Z J P Yang et al. (2015). "p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress".PMID 25501595
  99. Kayhan Basak et al. (2014). "Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report".PMID 25501093
  100. Yuko Kikuchi et al. (2015). "Human mediator MED17 subunit plays essential roles in gene regulation by associating with the transcription and DNA repair machineries".PMID 25482373
  101. Zhao Wei et al. (2015). "CUL4B impedes stress-induced cellular senescence by dampening a p53-reactive oxygen species positive feedback loop".PMID 25464270
  102. P C Kuo et al. (2015). "BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability".PMID 25461807
  103. Hyeon Seop Kim et al. (2014). "Reactive oxygen species increase HEPN1 expression via activation of the XBP1 transcription factor".PMID 25448679
  104. Tae Hyung Kim et al. (2015). "Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts".PMID 25445714
  105. Catia Giovannini et al. (2014). "Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma".PMID 25431954
  106. Jong Ho Park et al. (2014). "Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage".PMID 25406032
  107. Jian Chen et al. (2014). "CSN6 drives carcinogenesis by positively regulating Myc stability".PMID 25395170
  108. P W Voorneveld et al. (2015). "The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC".PMID 25393365
  109. Jing Wang et al. (2015). "Scrapie infection in experimental rodents and SMB-S15 cells decreased the brain endogenous levels and activities of Sirt1".PMID 25391763
  110. Francisco Ortiz et al. (2015). "Melatonin blunts the mitochondrial/NLRP3 connection and protects against radiation-induced oral mucositis".PMID 25388914
  111. Martina Magni et al. (2014). "Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis".PMID 25361978
  112. H H Lin et al. (2014). "Dynamic involvement of ATG5 in cellular stress responses".PMID 25341032
  113. Koichi Sakakura et al. (2015). "Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma".PMID 25338734
  114. Masaoki Kawasumi et al. (2014). "Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity".PMID 25336189
  115. Dejie Wang et al. (2014). "PLK1 and β-TrCP-dependent ubiquitination and degradation of Rap1GAP controls cell proliferation".PMID 25329897
  116. Ignacio Vega-Naredo et al. (2015). "Analysis of pro-apoptotic protein trafficking to and from mitochondria".PMID 25308496
  117. D Huhn et al. (2015). "miR-19, a component of the oncogenic miR-17∼92 cluster, targets the DNA-end resection factor CtIP".PMID 25308476
  118. Hairong Xu et al. (2015). "AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts".PMID 25307521
  119. Amanda P Beck et al. (2014). "Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta)".PMID 25296018
  120. Karita Peltonen et al. (2014). "Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress".PMID 25277384
  121. Masashi Idogawa et al. (2014). "Array-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cells".PMID 25277188
  122. Jaques Waisberg et al. (2014). "Overexpression of the ITGAV gene is associated with progression and spread of colorectal cancer".PMID 25275062
  123. Simona Gurzu et al. (2015). "The immunohistochemical profile of granular cell (Abrikossoff) tumor suggests an endomesenchymal origin".PMID 25262119
  124. Kais Kasem et al. (2014). "Adrenal oncocytic phaeochromocytoma with putative adverse histologic features: a unique case report and review of the literature".PMID 25252620
  125. Yuen Ngan Fan et al. (2014). "Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells".PMID 25250818
  126. Dongshi Chen et al. (2014). "TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity".PMID 25237903
  127. Eng Yen Huang et al. (2014). "Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation".PMID 25230151
  128. Zhenhong Hu et al. (2014). "Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells".PMID 25220870
  129. Zhenzhong Deng et al. (2014). "Late Cornified Envelope Group I, a novel target of p53, regulates PRMT5 activity".PMID 25220593
  130. Joseph Jebelli et al. (2014). "Microglial p53 activation is detrimental to neuronal synapses during activation-induced inflammation: Implications for neurodegeneration".PMID 25204787
  131. Gauri A Patwardhan et al. (2014). "Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells".PMID 25195822
  132. Joana Santos et al. (2014). "TRIM28/KAP1 regulates senescence".PMID 25160591
  133. Gisela Natalia Castro et al. (2015). "Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells".PMID 25155585
  134. Raju Adduri et al. (2014). "P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue".PMID 25152695
  135. Kemal Alpay et al. (2014). "Inhibition of c-Abl kinase activity renders cancer cells highly sensitive to mitoxantrone".PMID 25148385
  136. Anna B Wennerström et al. (2014). "Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines".PMID 25148029
  137. Akira Noguchi et al. (2014). "SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer".PMID 25146318
  138. Lester D R Thompson et al. (2015). "Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature".PMID 25141970
  139. Allen D Nicholson et al. (2014). "Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival".PMID 25127509
  140. Maja T Tomicic et al. (2014). "Translesion polymerase η is upregulated by cancer therapeutics and confers anticancer drug resistance".PMID 25125662
  141. Gloria G Curto et al. (2014). "Pax6 is essential for the maintenance and multi-lineage differentiation of neural stem cells, and for neuronal incorporation into the adult olfactory bulb".PMID 25117830
  142. Michael G Kemp et al. (2014). "DNA repair synthesis and ligation affect the processing of excised oligonucleotides generated by human nucleotide excision repair".PMID 25107903
  143. Aishwarya G Jacob et al. (2014). "Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways".PMID 25105592
  144. Lan Hui Li et al. (2014). "Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells".PMID 25105411
  145. A Vassilopoulos et al. (2015). "WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis".PMID 25088202
  146. Peijing Zhang et al. (2014). "ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1".PMID 25086746
  147. Rodrigo Portes Ureshino et al. (2014). "Inhibition of cytoplasmic p53 differentially modulates Ca(2+) signaling and cellular viability in young and aged striata".PMID 25084214
  148. Mary Ann Suico et al. (2014). "The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism".PMID 25081543
  149. Rebecca A Clewell et al. (2014). "Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage".PMID 25078064
  150. Garth Hamilton et al. (2014). "AKT regulates NPM dependent ARF localization and p53mut stability in tumors".PMID 25071014
  151. Tadashi Watanabe et al. (2014). "Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma".PMID 25063029
  152. Boris Sabirzhanov et al. (2014). "Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins".PMID 25057207
  153. Xiaodan Ji et al. (2014). "LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis".PMID 25053741
  154. Akinori Morita et al. (2014). "AS-2, a novel inhibitor of p53-dependent apoptosis, prevents apoptotic mitochondrial dysfunction in a transcription-independent manner and protects mice from a lethal dose of ionizing radiation".PMID 25026551
  155. S K Mungamuri et al. (2015). "Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters".PMID 25023704
  156. Marjanka J J M Mingels et al. (2014). "High prevalence of atypical hyperplasia in the endometrium of patients with epithelial ovarian cancer".PMID 25015863
  157. Bo Lin et al. (2014). "Human pluripotent stem cells have a novel mismatch repair-dependent damage response".PMID 25012654
  158. A Weilbacher et al. (2014). "RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38".PMID 25010984
  159. N Oi et al. (2015). "Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1".PMID 24998844
  160. Hyo Hyun Yang et al. (2015). "Inhibitory effects of (-)-loliolide on cellular senescence in human dermal fibroblasts".PMID 24993871
  161. María Costales et al. (2015). "Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model".PMID 24990098
  162. Takayoshi Yamauchi et al. (2014). "MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24".PMID 24980433
  163. Ravi Ranjan et al. (2014). "The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis".PMID 24970700
  164. Alan W Lau et al. (2014). "SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation".PMID 24959379
  165. Chun Kim et al. (2014). "Epidermal p65/NF-κB signalling is essential for skin carcinogenesis".PMID 24952939
  166. David R Micklem et al. (2014). "Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targets".PMID 24952598
  167. S Sreenivasa Reddy et al. (2014). "Altered ubiquitin-proteasome system leads to neuronal cell death in a spontaneous obese rat model".PMID 24949983
  168. Dimphna H Meijer et al. (2014). "An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells".PMID 24948806
  169. Kayhan Basak et al. (2014). "Effects of maternally exposed food coloring additives on laryngeal histology in rats".PMID 24941295
  170. L M A Schreurs et al. (2014). "Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer".PMID 24939624
  171. Ji Hoon Lee et al. (2014). "Direct activation of ATM by resveratrol under oxidizing conditions".PMID 24933654
  172. Daruka Mahadevan et al. (2014). "Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2".PMID 24893165
  173. A Garufi et al. (2014). "Degradation of mutant p53H175 protein by Zn(II) through autophagy".PMID 24874727
  174. Li Zeng et al. (2014). "Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells".PMID 24847310
  175. Silvia Carvalho et al. (2014). "SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint".PMID 24843002
  176. Koichi Shoji et al. (2014). "Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells".PMID 24839986
  177. H Lu et al. (2014). "Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice".PMID 24832598
  178. Gregory R Kardos et al. (2014). "Growth inhibitory effects of large subunit ribosomal proteins in melanoma".PMID 24807543
  179. Lei Pei et al. (2014). "DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death".PMID 24806680
  180. Y Senkiv et al. (2014). "Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin".PMID 24804557
  181. Mi Kyung Kim et al. (2014). "Expression profiles of epithelial-mesenchymal transition-associated proteins in epithelial ovarian carcinoma".PMID 24800235
  182. David I Brown et al. (2014). "Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts".PMID 24797518
  183. Christina Klaus et al. (2014). "TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas".PMID 24770931
  184. Johji Imura et al. (2014). "Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype".PMID 24765156
  185. Baomin Li et al. (2014). "Downregulation of the Werner syndrome protein induces a metabolic shift that compromises redox homeostasis and limits proliferation of cancer cells".PMID 24757718
  186. Melissa J Wilking et al. (2014). "SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation".PMID 24751483
  187. Sabine M Brouxhon et al. (2014). "Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis".PMID 24748654
  188. Rosalyn R Ram et al. (2014). "RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression".PMID 24732797
  189. Meenakshi Bhansali et al. (2014). "COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells".PMID 24725084
  190. Pauliina M Munne et al. (2014). "TP53 supports basal-like differentiation of mammary epithelial cells by preventing translocation of deltaNp63 into nucleoli".PMID 24722541
  191. Anthony E Rizzardi et al. (2014). "Evaluation of protein biomarkers of prostate cancer aggressiveness".PMID 24708576
  192. Helge Gad et al. (2014). "MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool".PMID 24695224
  193. Takahiro Matsumoto et al. (2014). "The GANT61, a GLI inhibitor, induces caspase-independent apoptosis of SK-N-LO cells".PMID 24694609
  194. M Girardot et al. (2015). "Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation".PMID 24681953
  195. SANIYA FAYZULLINA et al. (2014). "Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)".PMID 24667816
  196. Feng Wang et al. (2014). "JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation".PMID 24667498
  197. P P Wong et al. (2014). "Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer".PMID 24662835
  198. Min Ma et al. (2014). "Intracellular Theileria annulata promote invasive cell motility through kinase regulation of the host actin cytoskeleton".PMID 24626571
  199. Yoshihiro Kuga et al. (2014). "Cerebral and spinal cord tanycytic ependymomas in a young adult with a mutation in the NF2 gene".PMID 24612193
  200. Arianna Sabò et al. (2014). "SUMOylation of Myc-family proteins".PMID 24608896
  201. J Cheng et al. (2014). "A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways".PMID 24556694
  202. Nobuhiro Okada et al. (2014). "A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression".PMID 24532687
  203. Agoston T Agoston et al. (2014). "Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion".PMID 24529328
  204. Nahla E El-Ashmawy et al. (2014). "Biochemical/metabolic changes associated with hepatocellular carcinoma development in mice".PMID 24523022
  205. Zorka Milićević et al. (2014). "Identification of p53 and its isoforms in human breast carcinoma cells".PMID 24511294
  206. Bat Erdene Batsaikhan et al. (2014). "The role of activation-induced cytidine deaminase expression in gastric adenocarcinoma".PMID 24511045
  207. Birgit Berkenkamp et al. (2014). "In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells".PMID 24505380
  208. Naoki Miyazawa et al. (2014). "Human cell growth regulator Ly-1 antibody reactive homologue accelerates processing of preribosomal RNA".PMID 24495227
  209. M E Fiori et al. (2014). "Antitumor effect of miR-197 targeting in p53 wild-type lung cancer".PMID 24488097
  210. Erawan Borkham-Kamphorst et al. (2014). "The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling".PMID 24487063
  211. Florencia Facciuto et al. (2014). "Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein".PMID 24462519
  212. Chun lin Wang et al. (2014). "Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma".PMID 24445145
  213. Jennifer R Kulzer et al. (2014). "A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell".PMID 24439111
  214. María Luisa Hernández-Bule et al. (2014). "Molecular mechanisms underlying antiproliferative and differentiating responses of hepatocarcinoma cells to subthermal electric stimulation".PMID 24416255
  215. Richard O Adeyemi et al. (2014). "Parvovirus-induced depletion of cyclin B1 prevents mitotic entry of infected cells".PMID 24415942
  216. Kristina Heyne et al. (2014). "Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2".PMID 24413661
  217. Helmut Schweikl et al. (2014). "2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway".PMID 24411679
  218. Laura A Lindsey-Boltz et al. (2014). "Coupling of human DNA excision repair and the DNA damage checkpoint in a defined in vitro system".PMID 24403078
  219. Haruhiro Toko et al. (2014). "Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells".PMID 24375406
  220. Yanying Liu et al. (2014). "The proteasome function reporter GFPu accumulates in young brains of the APPswe/PS1dE9 Alzheimer's disease mouse model".PMID 24363091
  221. Min Qi et al. (2014). "DNAJB1 stabilizes MDM2 and contributes to cancer cell proliferation in a p53-dependent manner".PMID 24361594
  222. Yiqun Du et al. (2014). "NF-κB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack".PMID 24338025
  223. Kathleen I Pishas et al. (2014). "Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling".PMID 24336067
  224. Sun A Kim et al. (2014). "Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential".PMID 24321526
  225. Toshiaki Tanaka et al. (2014). "Knockdown of Sec8 promotes cell-cycle arrest at G1/S phase by inducing p21 via control of FOXO proteins".PMID 24299491
  226. E Zaganjor et al. (2014). "Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells".PMID 24240690
  227. Mengyao Guo et al. (2014). "Baicalin inhibits Staphylococcus aureus-induced apoptosis by regulating TLR2 and TLR2-related apoptotic factors in the mouse mammary glands".PMID 24211786
  228. Rui Zhang et al. (2014). "Effects of cyclic AMP response element binding protein-Zhangfei (CREBZF) on the unfolded protein response and cell growth are exerted through the tumor suppressor p53".PMID 24200963
  229. Kazuya Kusama et al. (2014). "The role of exchange protein directly activated by cyclic AMP 2-mediated calreticulin expression in the decidualization of human endometrial stromal cells".PMID 24169561
  230. Yi Yuan Huang et al. (2013). "BCCIP suppresses tumor initiation but is required for tumor progression".PMID 24145349
  231. Chandrashekara Kyathanahalli et al. (2013). "Cross-species withdrawal of MCL1 facilitates postpartum uterine involution in both the mouse and baboon".PMID 24140717
  232. A Meijer et al. (2013). "Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL".PMID 24136147
  233. Evgenia Gubanova et al. (2013). "SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways".PMID 24107632
  234. Jekaterina Kazantseva et al. (2013). "Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells".PMID 24098348
  235. Lu Yu et al. (2014). "Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma".PMID 24079261
  236. Adriana Ventura et al. (2014). "Analysis of the expression of p53 during the morphogenesis of the gastroesophageal mucosa of Gallus gallus domesticus (Linnaeus, 1758)".PMID 24068480
  237. S Fernandez et al. (2014). "A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop".PMID 24056966
  238. Xiaoze Li et al. (2013). "Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes".PMID 24039800
  239. Kimihide Kusafuka et al. (2014). "Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses".PMID 24038506
  240. Aihua Hou et al. (2013). "Comparison of gene expression profiles in primary and immortalized human pterygium fibroblast cells".PMID 24012806
  241. Yuyan Chen et al. (2013). "Tumor protein D52 represents a negative regulator of ATM protein levels".PMID 23974097
  242. Young Ju Jeong et al. (2013). "Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients".PMID 23969757
  243. Larissa Bazela Maschio et al. (2014). "Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast".PMID 23899963
  244. Shirley M H Sy et al. (2013). "The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks".PMID 23863847
  245. Yuyan Xiong et al. (2013). "Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability".PMID 23832324
  246. Jing Zhang et al. (2013). "An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy".PMID 23826420
  247. Yu Li et al. (2013). "Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs".PMID 23825667
  248. Yutaka Noda et al. (2013). "Prospective randomized controlled study comparing cell block method and conventional smear method for bile cytology".PMID 23808950
  249. Y Yuan et al. (2013). "Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells".PMID 23807219
  250. Carol R Bradford et al. (2014). "Biomarkers in advanced larynx cancer".PMID 23775802
  251. F Sangar et al. (2014). "Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis".PMID 23752192
  252. Olena Zakharchenko et al. (2013). "A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance".PMID 23741479
  253. I S Lauxen et al. (2014). "Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression".PMID 23738964
  254. Veronika A Glukhova et al. (2013). "Rapid assessment of RNAi-mediated protein depletion by selected reaction monitoring mass spectrometry".PMID 23713831
  255. Alejandro García-Regalado et al. (2013). "Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells".PMID 23693014
  256. Jin Yan Hao et al. (2012). "Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review".PMID 23691479
  257. G Bosco-Clément et al. (2014). "Targeting Gli transcription activation by small molecule suppresses tumor growth".PMID 23686308
  258. Camille Brochier et al. (2013). "Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons".PMID 23678107
  259. Ruchira S Ranaweera et al. (2013). "Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity".PMID 23671280
  260. Ye Wang et al. (2013). "Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway".PMID 23661372
  261. Havva Erdem et al. (2013). "Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: a microarray study".PMID 23625597
  262. Ginevra Licandro et al. (2013). "The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells".PMID 23619996
  263. A Moreno et al. (2014). "ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth".PMID 23604125
  264. Kensuke Kojima et al. (2013). "Prognostic impact and targeting of CRM1 in acute myeloid leukemia".PMID 23564911
  265. A P Sappino et al. (2012). "The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage".PMID 23552604
  266. Phillip G P Andrews et al. (2013). "Evidence of a novel role for Pygopus in rRNA transcription".PMID 23517060
  267. Vanmathy R Kasimanickam et al. (2013). "Immunolocalization of retinoic acid receptor-alpha, -beta, and -gamma, in bovine and canine sperm".PMID 23465288
  268. Nadine Martin et al. (2013). "Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation".PMID 23455154
  269. Christian Ulrich Huebbers et al. (2013). "Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis".PMID 23437342
  270. Youssef Yakkioui et al. (2014). "A comparison of cell-cycle markers in skull base and sacral chordomas".PMID 23416769
  271. Sean M Armour et al. (2013). "A high-confidence interaction map identifies SIRT1 as a mediator of acetylation of USP22 and the SAGA coactivator complex".PMID 23382074
  272. Yasumichi Kuwahara et al. (2013). "SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters".PMID 23364536
  273. Emilie Rass et al. (2013). "Ataxia telangiectasia mutated (ATM) is dispensable for endonuclease I-SceI-induced homologous recombination in mouse embryonic stem cells".PMID 23355489
  274. Likun Li et al. (2013). "Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2".PMID 23333597
  275. Ewa Olszewska et al. (2013). "The role of p21 and p53 proteins in congenital cholesteatoma".PMID 23324739
  276. Kazuaki Nakamura et al. (2013). "DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis".PMID 23320119
  277. K Penicud et al. (2014). "DMAP1 is an essential regulator of ATM activity and function".PMID 23318425
  278. Svetlana V Khoronenkova et al. (2013). "USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair".PMID 23275561
  279. Laure Crabbe et al. (2012). "Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assembly".PMID 23260663
  280. Lixian Wu et al. (2013). "BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks".PMID 23259762
  281. Linda Boldrup et al. (2012). "Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins".PMID 23230394
  282. Qingsheng Yan et al. (2013). "BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8".PMID 23230272
  283. Tianyi Zhang et al. (2012). "Competition between NBS1 and ATMIN controls ATM signaling pathway choice".PMID 23219553
  284. Marc Maserati et al. (2014). "Identification of four genes required for mammalian blastocyst formation".PMID 23211737
  285. Laurent Jullien et al. (2013). "Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response".PMID 23193277
  286. Kangmoon Lee et al. (2012). "Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts".PMID 23146670
  287. Luciano de Souza Viana et al. (2013). "Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination".PMID 23128103
  288. Sui Zhang et al. (2012). "Identification of the molecular basis of doxorubicin-induced cardiotoxicity".PMID 23104132
  289. Kristopher R Schwab et al. (2013). "Arrested spermatogenesis and evidence for DNA damage in PTIP mutant testes".PMID 23063797
  290. Kelly Coffey et al. (2012). "Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer".PMID 23056207
  291. Yonghua Liu et al. (2012). "SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway".PMID 23051735
  292. Rosanna Lau et al. (2012). "cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation".PMID 23032264
  293. Wensheng Yan et al. (2012). "HuR is necessary for mammary epithelial cell proliferation and polarity at least in part via ΔNp63".PMID 23028944
  294. Fabio Rotondo et al. (2014). "Atypical pituitary adenoma with neurocytic transformation".PMID 22914612
  295. Raffaele Frazzi et al. (2013). "Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation".PMID 22833338
  296. Sayuri Takayanagi et al. (2013). "Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress".PMID 22802018
  297. Jeremy E Purvis et al. (2012). "p53 dynamics control cell fate".PMID 22700930
  298. Matthew E Hardee et al. (2012). "Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β".PMID 22693253
  299. Benigno C Valdez et al. (2012). "Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines".PMID 22687754
  300. Camila Zogbi et al. (2012). "Gonocyte development in rats: proliferation, distribution and death revisited".PMID 22527699
  301. Dasa Dolezalova et al. (2012). "MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells".PMID 22511267
  302. In Hye Lee et al. (2012). "Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress".PMID 22499945
  303. Abhinav K Jain et al. (2012). "p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells".PMID 22389628
  304. Kirk W Simon et al. (2012). "Aging alters folate homeostasis and DNA damage response in colon".PMID 22306610
  305. Débora Aparecida Pires de Campos Zuccari et al. (2012). "An immunohistochemical study of interleukin-8 (IL-8) in breast cancer".PMID 22244449
  306. H G Rebel et al. (2012). "UV-induced ablation of the epidermal basal layer including p53-mutant clones resets UV carcinogenesis showing squamous cell carcinomas to originate from interfollicular epidermis".PMID 22227037
  307. Thibault Mesplede et al. (2012). "p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes".PMID 22013048
  308. Yin Wu et al. (2012). "Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial".PMID 22009819
  309. Bruna Victorasso Jardim et al. (2012). "Glutathione transferase pi (GSTpi) expression in breast cancer: an immunohistochemical and molecular study".PMID 22000861
  310. Aniek Janssen et al. (2011). "Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations".PMID 21960636
  311. Mi Jung Kwon et al. (2011). "Pituicytoma with unusual histological features".PMID 21951670
  312. Thanaa El A Helal et al. (2012). "Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors".PMID 21937259
  313. Pei Chi Wei et al. (2012). "Non-targeting siRNA induces NPGPx expression to cooperate with exoribonuclease XRN2 for releasing the stress".PMID 21908404
  314. Chiung Hui Liu et al. (2011). "Subamolide A, a component isolated from Cinnamomum subavenium, induces apoptosis mediated by mitochondria-dependent, p53 and ERK1/2 pathways in human urothelial carcinoma cell line NTUB1".PMID 21708241
  315. Tsuyoshi Kawabata et al. (2011). "A reduction of licensed origins reveals strain-specific replication dynamics in mice".PMID 21611832
  316. Paolo Benatti et al. (2011). "Specific inhibition of NF-Y subunits triggers different cell proliferation defects".PMID 21415014
  317. Y Huang et al. (2011). "Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells".PMID 21274007
  318. Raffaele Frazzi et al. (2011). "Increase in clusterin forms part of the stress response in Hodgkin's lymphoma".PMID 21240462
  319. Angelo G Scibetta et al. (2010). "Dual association by TFAP2A during activation of the p21cip/CDKN1A promoter".PMID 21084835
  320. Linwei Li et al. (2010). "The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma".PMID 20937111
  321. David Bungard et al. (2010). "Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation".PMID 20647423
  322. Hiroshi Hirata et al. (2011). "Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma".PMID 20549706
  323. Sergei Boichuk et al. (2010). "Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen".PMID 20519379
  324. Veronique Marsaud et al. (2010). "Cyclin K and cyclin D1b are oncogenic in myeloma cells".PMID 20459741
  325. Nagehan O Barisik et al. (2010). "Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study".PMID 20346139
  326. Andrea Lunardi et al. (2010). "A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network".PMID 20308539
  327. Hui Kuan Lin et al. (2010). "Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence".PMID 20237562
  328. Thomas G Fazzio et al. (2010). "Condensin complexes regulate mitotic progression and interphase chromatin structure in embryonic stem cells".PMID 20176923
  329. Jay P Reddy et al. (2010). "Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation".PMID 20133707
  330. Ken C Walls et al. (2010). "Lysosome dysfunction triggers Atg7-dependent neural apoptosis".PMID 20123985
  331. Carlos Escande et al. (2010). "Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice".PMID 20071779
  332. Laishram R Singh et al. (2010). "Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70".PMID 20066033
  333. Shinako Araki et al. (2010). "TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer".PMID 19955655
  334. Ying Geng et al. (2010). "Cytoplasmic p53 and activated Bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis".PMID 19901272
  335. Xiangzhi Li et al. (2009). "Two mammalian MOF complexes regulate transcription activation by distinct mechanisms".PMID 19854137
  336. Shin Ichiro Hayashi et al. (2009). "The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy".PMID 19815708
  337. M Udelhoven et al. (2010). "Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells".PMID 19755487
  338. Lisa S Chen et al. (2009). "Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells".PMID 19734450
  339. E Giaime et al. (2010). "Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6".PMID 19680261
  340. Hailing Cheng et al. (2009). "SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis".PMID 19622832
  341. Renyuan Zhou et al. (2010). "Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53".PMID 19609950
  342. Wei Qin Jiang et al. (2009). "Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins".PMID 19468068
  343. Alejo Efeyan et al. (2009). "Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression".PMID 19421407
  344. Bin Zhang et al. (2009). "Dosage effects of cohesin regulatory factor PDS5 on mammalian development: implications for cohesinopathies".PMID 19412548
  345. Noha Elmouelhi et al. (2009). "Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery".PMID 19326913
  346. Rene Rodriguez et al. (2009). "Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells".PMID 19308294
  347. Kee Hwan Yoo et al. (2009). "Endothelin A receptor blockade influences apoptosis and cellular proliferation in the developing rat kidney".PMID 19270827
  348. Wei Zhou et al. (2009). "EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations".PMID 19270820
  349. Shiro Mizuno et al. (2009). "Hypoxia regulates human lung fibroblast proliferation via p53-dependent and -independent pathways".PMID 19267931
  350. Xiaohong Wang et al. (2009). "Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6".PMID 19258450
  351. Jayasree S Nair et al. (2009). "Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780".PMID 19225156
  352. Surojit Sur et al. (2009). "A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53".PMID 19225112
  353. Deborah A Altomare et al. (2009). "Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice".PMID 19223589
  354. Keiko Kawauchi et al. (2009). "Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification".PMID 19202066
  355. Adriana S Hemerly et al. (2009). "Orc1 controls centriole and centrosome copy number in human cells".PMID 19197067
  356. Erin R P Shull et al. (2009). "Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS".PMID 19171781
  357. Elke A Jarboe et al. (2009). "Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma".PMID 19151662
  358. Olivier Ayrault et al. (2009). "Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma".PMID 19147535
  359. Wassim Chatoo et al. (2009). "The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity".PMID 19144853
  360. Eleonora Forte et al. (2009). "MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival".PMID 19144715
  361. Ivan Topisirovic et al. (2009). "Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer".PMID 19114552
  362. Shigeto Ueda et al. (2008). "Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer".PMID 19102762
  363. Saurabh Dayal et al. (2009). "Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53".PMID 19098288
  364. Yong Chul Kim et al. (2009). "Activation of ATM depends on chromatin interactions occurring before induction of DNA damage".PMID 19079244
  365. Ananta Gurung et al. (2009). "Beta-catenin is a mediator of the response of fibroblasts to irradiation".PMID 19036807
  366. Janine A Burns et al. (2009). "Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues".PMID 19001637
  367. Vladimir L Gabai et al. (2009). "Heat shock protein Hsp72 controls oncogene-induced senescence pathways in cancer cells".PMID 19001088
  368. Omedul Islam et al. (2009). "Interleukin-6 and neural stem cells: more than gliogenesis".PMID 18971377
  369. Stéphanie Solier et al. (2009). "Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways".PMID 18955500
  370. Jennifer Hein et al. (2009). "Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding".PMID 18922873
  371. M Wenghoefer et al. (2008). "Nuclear hBD-1 accumulation in malignant salivary gland tumours".PMID 18840281
  372. Yasuhiro Okumura et al. (2008). "Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion".PMID 18837981
  373. Kwou Yeung Wu et al. (2008). "Mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells".PMID 18806879
  374. Seong Hyun Jeong et al. (2008). "Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology".PMID 18772168
  375. Konstantinos J Mavrakis et al. (2008). "Tumorigenic activity and therapeutic inhibition of Rheb GTPase".PMID 18708578
  376. Jennifer M Rosenbluth et al. (2008). "A gene signature-based approach identifies mTOR as a regulator of p73".PMID 18678646
  377. Sven Gunia et al. (2008). "Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer".PMID 18648853
  378. Kristin E Yates et al. (2008). "Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts".PMID 18616636
  379. Mark Wade et al. (2008). "BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death".PMID 18604177
  380. Sanjeev Shangary et al. (2008). "Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer".PMID 18566224
  381. Jean Luc Perfettini et al. (2008). "Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia".PMID 18560558
  382. Jung Yoon Park et al. (2008). "Homeostatic imbalance between apoptosis and cell renewal in the liver of premature aging Xpd mice".PMID 18545656
  383. E Lecona et al. (2008). "Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase".PMID 18541673
  384. Li Zeng et al. (2008). "Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis".PMID 18523653
  385. Sonja Wolff et al. (2008). "p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity".PMID 18504456
  386. Leonie Smeenk et al. (2008). "Characterization of genome-wide p53-binding sites upon stress response".PMID 18474530
  387. Chunrong Yu et al. (2008). "Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells".PMID 18445700
  388. Suchismita Panda et al. (2008). "Modification of the ATM/ATR directed DNA damage response state with aging and long after hepatocyte senescence induction in vivo".PMID 18440596
  389. Nobuyuki Kikuno et al. (2008). "Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells".PMID 18431742
  390. Gunter von Minckwitz et al. (2008). "Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast".PMID 18380893
  391. Ryo Sakasai et al. (2008). "RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage".PMID 18337245
  392. Zhenhua Song et al. (2008). "Expression of senescence-related genes in human corneal endothelial cells".PMID 18334933
  393. Hua Chuan Zheng et al. (2008). "Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas".PMID 18266006
  394. Iman M Ahmad et al. (2008). "2-Deoxyglucose combined with wild-type p53 overexpression enhances cytotoxicity in human prostate cancer cells via oxidative stress".PMID 18155176
  395. Jie Zhou et al. (2008). "The antiapoptotic role of pregnane X receptor in human colon cancer cells".PMID 18096695
  396. Jin Hee Lee et al. (2008). "Frequent epigenetic inactivation of hSRBC in gastric cancer and its implication in attenuated p53 response to stresses".PMID 18059034
  397. G Strauss et al. (2008). "4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG".PMID 18034189
  398. Jing Qu et al. (2007). "Nitric oxide destabilizes Pias3 and regulates sumoylation".PMID 17987106
  399. Min Wang et al. (2007). "BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription".PMID 17878219
  400. Lukas M Orre et al. (2007). "Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling".PMID 17785350
  401. Douglas M Iddings et al. (2007). "Association of angiogenesis markers with lymph node metastasis in early colorectal cancer".PMID 17709727
  402. Marco A Napolitano et al. (2007). "Brg1 chromatin remodeling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells".PMID 17666433
  403. Thérèse Rachell Theodoro et al. (2007). "Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis".PMID 17603633
  404. Yunli Zhou et al. (2007). "Activation of p53 by MEG3 non-coding RNA".PMID 17569660
  405. Pabbisetty Sudheer Kumar et al. (2007). "Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells".PMID 17565690
  406. Juan M Funes et al. (2007). "Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production".PMID 17384149
  407. Ana Cuadrado et al. (2007). "A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis".PMID 17380123
  408. L H Meng et al. (2007). "Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288)".PMID 17297446
  409. Lauren F Stevenson et al. (2007). "The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2".PMID 17290220
  410. David Shackelford et al. (2006). "Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide".PMID 17145882
  411. Markus Christmann et al. (2006). "c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF".PMID 17130154
  412. Jian Hua Chen et al. (2006). "Deep senescent human fibroblasts show diminished DNA damage foci but retain checkpoint capacity to oxidative stress".PMID 17126333
  413. Lee J Martin et al. (2007). "Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death".PMID 17099894
  414. Laura M Rozan et al. (2006). "Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target".PMID 16969126
  415. Daniela Pasquali et al. (2006). "The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy".PMID 16763065
  416. Michael A James et al. (2006). "Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner".PMID 16699010
  417. Matthias Woenckhaus et al. (2007). "Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer".PMID 16698957
  418. Mariko Tomita et al. (2006). "Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells".PMID 16603085
  419. Jianwei Ren et al. (2006). "FAT10 plays a role in the regulation of chromosomal stability".PMID 16495226
  420. Raju V Pusapati et al. (2006). "ATM promotes apoptosis and suppresses tumorigenesis in response to Myc".PMID 16432227
  421. Sylwia Ammoun et al. (2006). "G-protein-coupled OX1 orexin/hcrtr-1 hypocretin receptors induce caspase-dependent and -independent cell death through p38 mitogen-/stress-activated protein kinase".PMID 16282319
  422. Xiangguo Liu et al. (2005). "Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity".PMID 16230375
  423. Roman Kulikov et al. (2005). "Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance".PMID 16055726
  424. Anja Duursma et al. (2005). "p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation".PMID 16055707
  425. Vaneeta Marwaha et al. (2005). "T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter".PMID 16046401
  426. Hideshi Ishii et al. (2005). "Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis".PMID 15983387
  427. Noriko Shirata et al. (2005). "Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection".PMID 15964848
  428. Shashirekha Shetty et al. (2005). "Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1".PMID 15964798
  429. Jean Francois Lavoie et al. (2005). "TrkA induces apoptosis of neuroblastoma cells and does so via a p53-dependent mechanism".PMID 15961390
  430. Michael Uhlin et al. (2005). "Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes".PMID 15958529
  431. Yuichi J Machida et al. (2005). "Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation".PMID 15944161
  432. Andrea Mueller et al. (2005). "The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity".PMID 15941720
  433. Armando Rivera et al. (2005). "The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway".PMID 15914462
  434. Ching Hao Li et al. (2005). "Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway".PMID 15905168
  435. Tetsuo Mashima et al. (2005). "p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target".PMID 15900046
  436. Lindsey D Mayo et al. (2005). "Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified".PMID 15843377
  437. Xiao Dong Zhou et al. (2005). "Expression of cellular FLICE-inhibitory protein and its association with p53 mutation in colon cancer".PMID 15832422
  438. Mark W Jackson et al. (2005). "p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2".PMID 15827088
  439. David Goldschneider et al. (2005). "The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells".PMID 15741235
  440. Andrew V Samuelson et al. (2005). "p400 is required for E1A to promote apoptosis".PMID 15741165
  441. Gita Ohlsson et al. (2005). "Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas".PMID 15734831
  442. Takayuki Hanamoto et al. (2005). "Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function".PMID 15723830
  443. Masanori Terai et al. (2005). "Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway".PMID 15647378
  444. Yunfei Ding et al. (2005). "NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer".PMID 15358636
  445. Dhananjay A Chitale et al. (2005). "Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray".PMID 15272278
  446. Mukul Mathur et al. (2003). "PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration".PMID 12902986
  447. Gerda Lagger et al. (2003). "The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene".PMID 12665570
  448. Chiun Chei Li et al. (2002). "Morules with optically clear nuclei in ovarian borderline endometrioid tumor".PMID 12588418
  449. Shi Nae Lee et al. (2002). "Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people".PMID 12483005
  450. James G Rheinwald et al. (2002). "A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status".PMID 12077343
  451. I Barshack et al. (2001). "Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue".PMID 11533074
  452. Y H Kang et al. (2001). "The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer".PMID 11511786
  453. J L Shenk et al. (2001). "p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction".PMID 11504717
  454. A Kale et al. (2001). "Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease".PMID 11262454
  455. M Zeng et al. (2000). "Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways".PMID 10987303
  456. M A Dickson et al. (2000). "Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics".PMID 10648628
  457. H Shiga et al. (1999). "Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer".PMID 10632346
  458. C R Bradford et al. (1999). "Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma".PMID 10547465
  459. E Hodak et al. (1999). "Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma".PMID 10218673
  460. S Nikol et al. (1998). "Restenosis in human vein bypass grafts".PMID 9699889
  461. M S Mateo et al. (1995). "p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections".PMID 7745116
  462. N Livni et al. (1995). "p53 expression in patients with cirrhosis with and without hepatocellular carcinoma".PMID 7736384